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PREFACE 
This dissertation describes the development of vapor deposited sol-gel particles 
for use in directing osteoblast behavior and their potential to be used in orthopedic tissue 
engineering constructs. Several chapters in this dissertation are in preparation for 
publication and/or are already published in scientific journals.  
Chapter 1 is a literature review, with background information on bone biology 
and osteoblast differentiation, approaches to treating damaged bone tissue, the effect of 
biomaterial properties on osteoblast behavior, and the use of sol-gels as biomaterials. It 
also includes the rationale, hypotheses, and specific aims for this dissertation.   
Chapter 2 covers the development and characterization of a silica sol-gel vapor 
deposition system that can be used to tailor the material properties of substrates. The data 
in this chapter is published in the Journal of Biomedical Research Part A (2012). I 
performed the majority of the research, with contributions by Hallie Holmes, Michael 
VanWagner, and Natalie Hartman on the degradation, contact angle and roughness 
analyses. Rupak Rajachar provided input and was a mentor on experimental design, 
analysis, and paper editing. However, the conclusions presented are my own, and I am 
the main author for this publication. 
Chapter 3 covers the characterization of particle properties when calcium and 
phosphate ions are incorporated. The data in this chapter is being prepared for 
publication. I performed the majority of the research with contributions by Hallie Holmes 
the contact angle analysis. Rupak Rajachar provided input and was a mentor on 
experimental design, analysis, and paper editing. However, the conclusions presented are 
my own, and am the main author for this publication. The data in this chapter is being 
prepared for submission to the Journal of Biomedical Matierals Part A.  
Chapter 4 assesses the response of osteoblasts to vapor deposited calcium-
phosphate sol-gel particles. The data in this chapter is being prepared for publication. I 
performed the research and am the main author for this publication. Rupak Rajachar 
provided input and was a mentor on experimental design, analysis, and paper editing The 
data in this chapter is being prepared for submission to the Journal of Biomedical 
Matierals Part A.  
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Chapter 5 is a summary of all findings and conclusions reached in this 
dissertation.  
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DEFINITIONS 
Alkaline Phosphatase  Enzyme localized on cell membranes found in all tissues 
and in high concentration in bone, kidneys, intestines, 
biliary ducts, plasma, and teeth that hydrolyzes phosphate 
esters liberating inorganic phosphate. In bone, used as a 
marker of osteoblast differentiation and bone remodeling  
 
Collagen  Structural protein found in connective tissues. In bone 
tissues, it is the main organic constituent and is secreted by 
osteoblasts  
 
Cyclophilin Protein found in all cells exhibit peptidyl-prolyl cis-trans 
isomerase (PPIase) activity which facilitates protein folding  
 
Hydroxyapatite The main inorganic constitute of bone and tooth enamel 
(Ca10(PO4)6(OH)2) 
 
in vitro Procedure that takes place in a controlled environment 
outside of a living organism (i.e., laboratory, test tube, 
culture dish) 
 
in vivo    Procedure that takes place inside a living organism 
 
MC3T3-E1 An immortalized cell line of osteoblast precursors derived 
from mice 
 
Osteoblast  Cell that secretes bone matrix and is responsible for the 
formation of bone 
 
x 
 
 
 
Osteocalcin  Calcium-binding noncollagenous bone matrix protein 
secreted by osteoblasts that is involved in regulating 
mineralization in the bones and teeth and is used as an 
osteoblast differentiation marker 
 
Osteopontin   Calcium-binding noncollagenous bone matrix protein 
secreted by osteoblasts that plays a role in bone remodeling 
and various immunological functions and is used as an 
osteoblast differentiation marker (also known as bone 
sialoprotein 1, BSP-1)  
 
Runx2 Key transcription factor associated with differentiation of 
osteoblasts (also known as core-binding factor subunit 
alpha-1, Cbfa1) 
 
Ubiquitin Small regulatory protein present in almost all cells that 
attaches to proteins tags them for proteolysis 
  
xi 
 
 
 
ABBREVIATIONS 
α-MEM   Alpha-modified minimal essential medium 
AFM     Atomic force microscopy 
ALP     Alkaline phosphatase 
ANOVA   Analysis of variance 
Ca     Calcium 
cDNA     Complementary deoxyribonucleic acid 
COLI     Type I collagen 
DAPI     4',6-diamidino-2-phenylindole 
DMEM    Dulbecco’s modified eagle medium 
DTT    Dithiothreitol 
ECM     Extracellular matrix 
EDS.    Energy dispersive X-ray spectrometry 
FBS     Fetal bovine serum 
FE-SEM    Field emission scanning electron spectroscopy 
FTIR    Fourier transform infrared spectroscopy 
GOI    Genes of interest 
HA     Hydroxyapatite  
HCl    Hydrochloric acid 
HK     Housekeeping genes 
NBF     Neutral buffered formalin  
OCN     Osteocalcin 
OPN     Osteopontin 
P     Phosphate 
P/S     Penicillin-streptomycin 
PBS    Phosphate buffered saline 
PCR     Polymerase chain reaction 
PLLA     Poly-L-lactide acid 
PS     Polystyrene 
RNA    Ribonucleic acid 
xii 
 
 
 
Runx2     Runt-related transcription factor 2  
SEM    Standard error of the mean 
TCPS     Tissue-culture treated polystyrene 
TEP     Triethyl phosphate 
TMOS    Tetramethyl orthosilicate 
Tris-HCl Tris(hydroxymethyl)aminomethane-hydrochloric acid  
TRITC    Tetramethyl rhodamine iso-thiocyanate 
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ABSTRACT 
Tissue engineering and regenerative medicine have emerged in an effort to 
generate replacement tissues capable of restoring native tissue structure and function, but 
because of the complexity of biologic system, this has proven to be much harder than 
originally anticipated. Silica based bioactive glasses are popular as biomaterials because 
of their ability to enhance osteogenesis and angiogenesis. Sol-gel processing methods are 
popular in generating these materials because it offers: 1) mild processing conditions; 2) 
easily controlled structure and composition; 3) the ability to incorporate biological 
molecules; and 4) inherent biocompatibility. The goal of this work was to develop a 
bioactive vaporization system for the deposition of silica sol-gel particles as a means to 
modify the material properties of a substrate at the nano- and micro- level to better mimic 
the instructive conditions of native bone tissue, promoting appropriate osteoblast 
attachment, proliferation, and differentiation as a means for supporting bone tissue 
regeneration. The size distribution, morphology and degradation behavior of the vapor 
deposited sol-gel particles developed here were found to be dependent upon formulation 
(H2O:TMOS, pH, Ca/P incorporation) and manufacturing (substrate surface character, 
deposition time). Additionally, deposition of these particles onto substrates can be used to 
modify overall substrate properties including hydrophobicity, roughness, and topography. 
Deposition of Ca/P sol particles induced apatite-like mineral formation on both two- and 
three-dimensional materials when exposed to body fluids. Gene expression analysis 
suggests that Ca/P sol particles induce upregulation osteoblast gene expression (Runx2, 
OPN, OCN) in preosteoblasts during early culture time points. Upon further 
modification-specifically increasing particle stability-these Ca/P sol particles possess the 
potential to serve as a simple and unique means to modify biomaterial surface properties 
as a means to direct osteoblast differentiation.  
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CHAPTER ONE: INTRODUCTION 
BACKGROUND AND SIGNIFICANCE 
Each year millions of people suffer from tissue loss or failure making it one of the 
most frequent, devastating, and costly problems in human healthcare. Specifically, for 
bone, 5-10% of the six million bone fractures that occur annually in the U.S. result in 
nonunions or delayed unions indicating there is a growing need for the development of 
material substitutes and therapies to help overcome this problem [1]. Consequently, the 
fields of tissue engineering and regenerative medicine have emerged in an effort to 
incorporate the fundamentals of engineering (mechanics and materials) and biological 
functions (cell and gene products) to generate replacement tissues capable of restoring 
native tissue structure and function [2]. Because of the complexity of biologic systems, it 
has proved to be much harder to design substitute matrices for cells than originally 
anticipated. Cells are affected by the chemical and molecular composition of the 
implanted material, as well as by its physical (i.e. topography and mechanical) properties. 
Development of materials that utilize the relationships between cells and material 
chemical, physical, and mechanical properties may provide a better platform for tissue 
regeneration [3]. Silica sol-gel bioactive glasses have become increasingly popular for 
use in tissue engineering materials due to their simple processing methods into a variety 
of shapes, the ease of control over composition and structure, and inherent 
biocompatibility [4-7]. The goal of this work was to develop and characterize a 
bioactive silica sol-gel surface modification system that can be used to coat materials 
in order to tailor their material properties at the nano- and micro- level to better 
mimic the instructive conditions of native bone tissue, promoting appropriate 
osteoblast attachment, proliferation, and differentiation as a means for supporting 
bone tissue regeneration.  
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BONE BIOLOGY 
Bone Composition 
Bone is a composite material composed of roughly 22-35% organic phase, 60-
70% inorganic phase, and 5-8% water (Figure 1.1A). The organic phase is made up of 
90% type I collagen fibers with the other 5% consisting of glycoproteins, and 
glycosaminoglycans (GAGs). The inorganic phase is composed primarily of 
hydroxyapatite (HA) crystals (Ca10(PO4)6(OH)2). There are two theories of how this 
mineral is incorporated into the collagen fibers: (1) direct nucleation and (2) matrix 
vesicle (MV) mediated matrix mineralization [8-12]. In direct nucleation, stable mineral 
droplets of calcium phosphate cluster-bipolymer complexes bind to regions on collagen 
fibers and diffuse through the fibrils where they solidify into an amorphous mineral, 
which is then transformed into orientated apatite crystals in the direction of the collagen 
fibers (Figure 1.1B) [8]. MV mediated matrix mineralization is based on calcium 
phosphate crystals contained within matrix vesicles that are produced by osteoblasts. 
Suggested mechanisms for this include: (i)  matrix vesicles regulate ion concentrations, 
leading to the formation of soluble molecular species that initiate mineral formation in 
the collagen fibrils, (ii) matrix vesicles regulate ion compositions leading to the formation 
of intravesicular apatite crystals that leave the vesicle and initiate mineralization; and (iii) 
matrix vesicles directly associate with the collagen to initiate mineralization (Figure 
1.1C)[8, 13]. The rigid HA crystals provide the compressive strength of bone, while the 
collagen fibers contribute to bone’s high tensile properties. Embedded in this matrix are 
osteoblasts, osteocytes, and osteoclasts [14-17]. Cortical bone has a porosity of 5-10% 
and its structural unit is the osteon (also called haversian systems), composed of 
concentric layers of bone (lamellae). Lacunae are small cavities within the bone matrix 
that contain osteocytes. Micro-scale canals called canaliculi radiate outward from a 
central canal (Haversian canal) and connect lacunae to one another, allowing for nutrient 
dispersal. Haversian canals are located in the center of each osteon and contain blood 
vessels and never fibers. At the periphery of each osteon is a cement line, an area of 
ground substance composed mostly of GAGs. Collagen fibers and canaliculi do not cross 
the cement line [18]. Osteons are arranged longitudinally, making the properties of 
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cortical bone anisotropic.  In the longitudinal direction, bone strength varies from 79-
151MPa in tension and 131-224MPa in compression. The moduli ranges from 17-20GPa 
in both tension and compression [14]. Trabecular bone is more porous that cortical bone 
(50-90%) and is made up of trabeculae, which are most often characterized as rod or plate 
like structures. Trabeculae consist of lamellae containing osteocytes in lacunae connected 
by canaliculi. However, unlike cortical bone, the lamellae are not concentrically arranged 
and do not contain central canals with blood vessels [18]. Trabecular bone also exhibits 
anisiotropy. Because of the increased porosity, trabecular bone has lower ultimate 
strength and modulus of elasticity, but can withstand greater strains than cortical bone 
[19]. 
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Figure 1.1 Structure of compact and spongy bone and apatite formation. (A) Cortical bone is organized 
into osteons composted of concentric lamellae around the Haversian canal with lacunae containing 
osteocytes connected by canaliculi.   Cacellous bone is composed of more porous trabeculae. From SEER 
Training Module [20]. Theories of collagen mineralization in bone include: (B) direct nucleation of CaP 
crystals [(i) CaP clusters form complexes with biopolymer to form (ii) stable mineral droplets. (iii) The 
droplets bind to regions of collagen fibers and (iv) form an amorphous phase by diffusing through the fibrils. 
(iv) The amorphous phase becomes orientated apatite crystals in the direction of the collagen fibers] and (C) 
MV mediated matrix mineralization [(i)  matrix vesicles regulate ion concentrations, leading to the formation 
of soluble molecular species that initiate mineral formation in the collagen fibrils, (ii) matrix vesicles regulate 
ion compositions leading to the formation of intravesicular apatite crystals that leave the vesicle and initiate 
mineralization; and (iii) matrix vesicles directly associate with the collagen to initiate mineralization]. From 
Chai et al. with permission (see Appendix A) [12]. 
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Osteoblast Differentiation 
Osteoblasts descend from mesenchymal stem cells, which can differentiate into 
many different cell types including adipocytes, myoblasts, fibroblasts, chondrocytes, and 
osteoblasts. The process of differentiation of these pluripotent cells into osteoblasts is 
complex and controlled by morphogens, hormones, growth factors cytokines, matrix 
proteins, and the expression of lineage-specific master transcription regulators and their 
co-regulatory proteins [21]. The differentiation of osteoblasts is regulated by the master 
transcription factor Runx2, with the help of other transcription factors including but not 
limited to osterix, ATF4, SMADs, NFATc1/calcineurin, Twist, AP-1, and TCF/LEF [22]. 
These transcription factors have many different signaling systems including the Wnt/β-
catenin, the BMP/TGFβ, the Notch, the Hedgehog, and the FGF signaling pathways [21].   
Following a lineage commitment, osteoprogentitor cells undergo a distinct 
temporal sequence of gene expression that has three distinct periods: (1) proliferation and 
ECM biosynthesis; (2) ECM development, maturation and organization; and (3) 
extracellular matrix mineralization [21-23] (Figure 1.2).   
Proliferation and Extracellular Matrix Synthesis (Days 1-12 in isolated cell 
culture): During this stage, cells proliferate to form multilayers or focal nodules. This 
stage is characterized by mitotic activity where cell cycle (e.g. histones which help 
package newly replicated DNA) and cell growth (e.g. c-fos, c-jun, c-myc which act as 
transactivation factors) genes are expressed. Genes for proteins associated with the 
extracellular matrix are also expressed including type I collagen and fibronectin (cell 
attachment ECM protein) [21-23]. The expression of these genes gradually decline, with 
type I collagen expression maintained at a basal level in future stages of osteoblast 
differentiation [23].   
Extracellular Matrix Development, Maturation and Organization (Days 12-18 in 
isolated cell culture): As these cells exit mitosis they further differentiate into osteoblasts 
and begin expressing genes such as alkaline phosphatase (ALP), bone sialoprotein (BSP), 
and type I collagen [21-23]. ALP is a noncollagenous cell-linked polypeptide that is 
secreted by osteoblasts and promotes crystal formation in matrix vesicles by removing 
nucleation inhibitors and is often considered one of the earliest markers of the osteoblast 
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phenotype. BSP is a noncollagenous ECM protein that is associated with cell attachment 
and is also thought to help direct apatite crystal growth along collagen fibers [24]. During 
this phase, signaling events occur, and a large cuboidal shaped osteoblast develops from 
the spindly shaped pre-osteoblast. These cells are responsible for causing the ECM to 
undergo a series of modifications in composition and organization so that it can begin 
mineralization. As mineralization increases, cellular expression of ALP (often considered 
one of the earliest markers of the osteoblast phenotype) will decrease [23].   
Extracellular Matrix Mineralization (Days 16-20 in isolated cell culture): As 
osteoblast differentiation continues, the cells begin to express genes involved in ECM 
mineralization including osteocalcin, osteopontin, and collegenase. Osteocalcin, a 
vitamin K dependent calcium ion binding noncollagenous matrix protein, is thought to 
play a role in the body's metabolic regulation. It is also implicated in bone mineralization 
and calcium ion homeostasis as well as thought to play a role in bone resorption. 
Osteocalcin is only expressed post-proliferation with the onset of nodule formation. 
Osteopontin, also a calcium ion binding noncollagenous matrix protein associated with 
cell attachment and spreading within the matrix, is expressed during the proliferation 
stage, decreases during the ECM maturation stage and is induced at the onset of 
mineralization, where it reaches is maximum expression levels. Collagenase expression 
begins after the proliferation stage and increases with mineralization, most likely 
associated with the remodeling of the collagen ECM to support tissue organization and 
mineral deposition. Cell apoptosis also occurs during this phase, possibly as a way of 
regulating the number of osteoblasts that differentiate into osteocytes [21-23]. 
Mineralization of the matrix occurs in two steps: (1) Nucleation of calcium-phosphate 
crystals and (2) crystal growth. Nucleation usually occurs in matrix vesicles, [small 
membrane bound organelles containing alkaline phosphatase (cleaves phosphate 
groups)], secreted by osteoblasts undergoing apoptosis and from cell processes 
originating from the plasma membrane. Ion pumps are used to raise the levels of calcium 
and phosphate within the vesicles. When the levels are above supersaturation, nucleation 
occurs on the inner face of the membrane first. The vesicles then rupture and the crystals 
continue to grow in between the collagen fibers within the ECM [24]. A portion of 
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osteoblasts that become embedded into the mineralized matrix can terminally 
differentiate to become osteocytes, which support bone structure and metabolic functions. 
Other osteoblasts are thought to become inactivated and elongated bone lining cells 
which line the surfaces of bone [21].   
Figure 1.2 Osteoblast differentiation. Osteoblast phenotype and temporal protein sequence during 
differentiation from stem cell to mature osteobalast/ostocytes.  Bold genes common markers chosen for 
osteoblastic differentiation. 
TREATMENT OF DAMAGED TISSUES 
 Biologic and Synthetic Grafts 
Traditional methods of surgical treatment of bone injuries include biologic grafts 
as well as permanent artificial prostheses. They can be classified as three types-autogenic, 
allogenic, and xenogenic. Autografts (taken from host) are limited by the amount of 
donor tissue available as well as the fact that a second surgical site must be created, often 
creating donor site morbidity and weakening of a second tissue. Allografts (taken from 
host of the same species) pose antigenicity problems and are in limited supply, especially 
in emergency situations. While xenografts (taken from a different species) may be readily 
available, they pose significant immunogenic problems [14, 25-27]. Synthetic prostheses 
are often made out of metals such as iron, cobalt, and titanium, and/or ceramic materials. 
Metal implants often have issues with fatigue, corrosion, tissue infection, while both 
metal and ceramic implants have issues mechanical property mismatches between the 
7 
 
 
 
material and bone, often resulting in complete implant removal in the long term [14, 28-
31]. The most significant deficiency with any of the current grafting systems in both soft 
and hard tissue is the lack of integration of the graft to bone tissue. Additionally, there are 
often immunogenic and/or material property mismatches, leading to decreased integration 
of the implant with bone tissue [27, 32]. Current existing grafting systems, both biologic 
and synthetic, are not able to restore tissues to their native structural and functional 
characteristics, leading to compromised graft function and long-term outcome [27, 32].  
Tissue Engineering 
Tissue engineering is a promising approach to creating permanent solutions for 
damaged tissues that aims to develop biological substitutes capable of restoring natural 
structure and function to damaged tissue [2, 14, 25, 33]. Currently, many materials are 
being used, either alone or in blends for bone reconstruction including but not limited to, 
natural polymers such as chitin, glycosaminoglycans (hyaluronic acid, heparin, 
chondroitin-6-sulphate), alginate, fibrin, collagen, and silk,  as well as synthetic polymers 
like polyglycolic acid (PGA)/polylactic acid (PLA), poly-e-caprolactone, polyethylene 
terephthalate, and polypropylene [25, 34-42].  Many of these scaffolds often also 
incorporate additional materials including growth factors [bone morphogenic proteins 
(BMPs), vascular endothelial growth factor (VEGF), platelet derived growth factor 
(PDGF)], proteins [parathyroid hormone (PTH), alkaline phosphatase (ALP), fibronectin] 
and calcium/phosphate based ceramics [tricalcium phosphate (TCP), hydroxyapatite 
(HA), Bioglass™ (45S5: 46.1 mol% SiO2, 26.9 mol% CaO, 24.4 mol% Na2O,  
2.5 mol% P2O5)] in effort to further enhance scaffold osteogenic potential [43-51].  
MATERIAL PROPERTIES INFLUENCE CELL BEHAVIOR  
In order to regenerate tissues successfully, the materials used in constructs should 
be chosen carefully. The chemical, physical, and mechanical properties of a material can 
affect cell behavior in multiple ways including attachment, morphology, proliferation, 
and gene expression. Specific cell behavior can be with property-cell interactions have 
been thoroughly characterized. Surface chemistry, hydrophobicity, roughness, 
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topography, and mechanical properties all play a role in influencing cell behavior. Many 
studies have investigated the role of these parameters on cell behavior, but few have 
isolated individual properties, making it difficult to determine the extent a single property 
has in influencing cell behavior and also leading to sometimes conflicting conclusions. 
This interdependency of materials properties makes it important to fully characterize a 
material when examining cell-material interactions.   
Surface Chemistry 
Surface chemistry dictates at the outset the surface character of a material and can 
be one of the earliest and most influential material properties on cell behavior. However, 
it is difficult to make generalizations about the effect of surface chemistry on cell 
behavior due to the sheer number of material choices and surface modifications available. 
The chemistry of the exposed groups on a material’s surface clearly affects cell behavior, 
though the mechanisms are not always understood [52]. Surface charge and released ions 
change how serum proteins and ions will interact and adsorb to the material, further 
altering the surface chemistry of the material and influencing cell behavior. Osteoblasts 
have been found to have increased attachment, proliferation, and differentiation on 
charged surfaces and/or surfaces that release ions, possibly due to increases in the 
concentration of ions and the ionic conditions needed for mineralization [53].  
Surface Hydrophobicity 
Surface hydrophobicity (wettability) refers to the interactions between a 
material’s surface and water. Because water has a high capacity for bonding (i.e., Lewis 
acid-base interactions), materials with a high surface energy have more contacts for 
bonding, making them generally more hydrophilic. Contact angle measurement is the 
simplest way of measuring surface hydrophobicity, with the most common technique 
being the sessile drop method. The angle formed at the liquid-solid interface is the 
contact angle (θ), which can range from 0 to 180°. Depending on the material’s 
hydrophobicity the droplet will take a different shape-for  more hydrophobic surfaces the 
droplet will stay rounded (larger angle), while on more hydrophilic surfaces the droplet 
will spread out (smaller angle) (Figure 1.3). Relative surface hydrophobicity of a 
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material is one of the first properties to influence cells when exposed to a material. 
Osteoblasts have been found to respond to surface hydrophobicity in a time dependant 
manner. Osteoblasts cultured on hydrophobic surfaces have delayed attachment and 
remain rounded for a longer period of time than on more hydrophilic surfaces. However, 
over time the surviving cells on the hydrophobic surface will eventually attach, flatten, 
and spread out across the surface, possibly due to the secretion of ECM proteins that 
remodel the substrate surface [54].  Many studies have found that fibroblasts attach, 
spread, and proliferate best on surfaces with hydrophilic character, with some studies 
determining the strongest affinity for moderately hydrophilic surfaces, also in a time 
dependent manner [55-58]. When determining the effect of surface hydrophobicity on 
cell attachment, spreading, and proliferation, it is important to measure the correct time 
points-measuring too early may give incorrect information about long-term cell survival 
on substrates, while measuring too late will give little information about initial cell 
interactions with the material [54]. More recently, evidence suggests that a cell’s 
activation state and not just adhesion must be considered in evaluating cell response to 
materials [59].  
Figure 1.3. Contact angle measurements. Schematic of how contact angle would look on a (A)  
hydrophobic surface and (B) a hydrophilic surface. Young’s equation relates the balance of forces of a liquid 
drop on a solid surface. 
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Surface Roughness   
Surface roughness is often quantified by the arithmetic mean roughness (Ra) and 
the root mean square roughness (RRMS or Rq). Ra is defined as the average distance 
between surface peaks and valleys relative to the center plane of the surface and RRMS is 
defined as the root mean square average of the profile height deviations from the center 
plane, recorded within the evaluation length (Figure 1.4A) [60]. While these values 
describe the overall roughness of the material surface they do not describe the material 
topography and features. Therefore, two surfaces with similar Ra and RRMS values can 
appear very different macroscopically (Figure 1.4B) [61]. In general it has been found 
that osteoblasts attach better to rough surfaces while fibroblasts to smooth surfaces. Many 
studies show that surface roughened implants promote osseointegration better than their 
smooth counterparts, which tend to promote fibroblast adhesion [62-67]. Surface 
roughness increases material surface area, potentially resulting in more opportunities for 
cells to establish adhesive contact with a material [61]. Osteoblasts have better adhesion, 
larger cell spreading, higher proliferation, and enhanced differentiation on substrates with 
an increased surface roughness [68-72].  
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Figure 1.4. Surface roughness measurements. (A) Surface roughness is often expressed as arithmetic 
roughness (Ra) or root mean square roughness (RRMS or Rq). (B) Electrospun fibers with similar RRMS values 
but distinctly different topographies (scale bar =10µm). Modified from Ricotti et al. with permission (see 
Appendix A) [73].  
Topography 
Many studies of have been done to investigate the effect of specific surface 
topography on cell behavior including groves/grates, posts/islands, and pits created on 
different metals and polymers. Cell attachment, morphology, proliferation and gene 
expression have been found to be influenced by substrate topography as small as 100nm 
in width and 75nm in depth, though cell response differs depending on cell type and 
feature size and geometry [74]. In general, nano- and micro- grates have been found to 
enhance cell attachment, elongate cell morphology, align cells with the nanogratings, and 
lower proliferation rates [70, 74]. The effect of nanopost and nanopit on cell behavior is 
more varied, with different combinations of substrate material, feature geometries, and 
cell types producing differing effects on cell attachment and proliferation [74]. Both 
osteoblasts and fibroblasts cultured on substrates containing randomly sized and 
orientated nanoposts of varying heights had higher cell attachment, spreading, 
proliferation and differentiation on surfaces containing shorter nanoposts than on 
substrates containing taller structures [75, 76]. Mesenchymal stem cells cultured on 
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substrates containing nanopits differentiate into either fibroblasts or osteoblast depending 
on the order or disorder of the nanopit arrays. Cells cultured on highly ordered arrays 
produce cells with fibroblastic appearances, while cells on arrays that were more irregular 
produced cells with an osteoblastic morphology and gene expression [77].  
Mechanical Properties 
Cells commonly attach to its surrounding extracellular matrix, which have an 
elastic moduli ranging from 10 to 10,000Pa depending on the tissue.  Therefore, cell 
morphology and function can be strongly influenced by substrate stiffness [78].  
Fibroblasts grown on softer substrates, show few actin stress fibers and focal adhesions 
and diminished cell spreading than on stiffer surfaces [78-80].  Osteoblasts cultured on 
surfaces with higher elastic moduli had enhanced differentiation and mineralization [81].  
Substrate mechanical properties can also affect cell proliferation and differentiation- 
mesenchymal stem cells can be differentiated into neurogenic, myogenic, or osteogenic 
cell types by changing the stiffness of the material to mimic that of the native tissue [80].  
In vivo, it is important to match the mechanical properties of a tissue engineering scaffold 
as closely to that of the tissue aiming to be regenerated so that there is not a compliance 
mismatch and to provide structural stability to the injury site [82].  
SOL-GEL METHODS FOR GENERATING BIOACTIVE GLASSES 
Bioactive glasses are silica-based materials whose matrices are porous gels 
obtained by the hydrolysis and condensation-polymerization of metallic alkoxides usually 
based on silicon dioxide (SiO2) network materials [83]. These materials are attractive 
because of their ability, when exposed to body fluids, to generate a dynamic bio-reactive 
surface microenvironment that can act as a strong bonding interface between the glass 
and its hard or soft tissue environment, giving them an inherent biocompatibility [84].  
The use of sol-gel processing methods is increasingly popular as a technique for 
generating bioactive glass-ceramic materials because of the mild processing conditions 
(ambient temperatures and biologically tolerated by-products) and simple methods for 
controlling composition and structure through synthesis parameters [6, 85]. Additionally, 
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these materials can be used as delivery vehicles for various inorganic and organic small 
molecules including ions, drugs, enzymes, antibodies, growth factors, DNA and even 
cells [7, 86-92]. Sol-gel materials can be generated in the form of fibers, powders, 
xerogels, aerogels, nanoparticles, and thin films [6, 93-98].  Potential biomedical uses of 
sol-gel materials include: nanoparticles used in magnetic resonance imaging (MRI), 
targeted drug delivery, and magnetic separation; surface coatings for metal surgical tools, 
implants, and optical and electrochemical biosensors; and scaffolds for tissue engineering 
[6]. Because of the attractive processing conditions and flexibility of their composition, 
bioactive glasses and ceramics are widely being explored to replace or augment both hard 
and soft tissues [99]. These materials further possess the capacity to exert an inherent 
active influence on cell behavior; modulated in part by surface chemistry, topography, 
and active agents incorporated in the sol-based material.  However, the exact balance of 
these parameters that is most appropriate for directing cell function and gene expression 
is not fully understood and warrants further exploration [100, 101]. 
Sol-gel processing methods produce ceramic materials from a colloidal 
suspension of precursors (sol). The solvent is removed from the system in order to 
solidify the material (gel). Precursors are usually metallic alkoxide compounds (Si-(OR)n, 
where R is an organic group) such as tetraethyl- or tetramethyl-orthosilicate (TEOS and  
TMOS respectively) [102]. Reactions carried out with TMOS are more volatile and 
consequently more energetic, so preparation of less bulky higher S/V ratio ceramics is 
much more amenable to the use of TMOS [103]. In the presence of water, the alkoxide 
groups are hydrolyzed, creating silanol groups and releasing alcohol. Condensation 
between silanol groups then occurs, creating Si-O-Si bonds. Extension of this reaction 
leads to a silica network with pores created through the removal of water and alcohol 
molecules. As the polycondensation reaction continues, colloidal mircro-particles are 
formed (Figure 1.5). This colloidal solution can then be cast into shapes or used as a 
coating. Over time the colloidal silica particles link together, increasing the viscosity of 
the solution, to form a solid three-dimensional network (gel). The size, growth rate, and 
amount of cross-linking within the particles are dependent upon several variables (e.g. sol 
pH and water-alkoxide ratio) that help determine the overall physical properties of the gel 
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network [83, 85]. Gels can then be cured with elevated temperatures, UV radiation, or 
“aged” by storing at room temperature to increase material density. Body temperature 
curing is also possible if the final material form has suitable physical properties (i.e. high 
S/V in the form of particles or thin-film coatings) [102].   
Additionally, inorganic-organic hybrid sol-gel materials can be formed by the 
additional of a polymer early on in the sol-gel process, during the condensation phase, in 
order to generate a composite material that interacts at the nano-scale and behave as a 
single phase material. These hybrid materials are beneficial because they improve the 
mechanical and degradation properties of the bioglass [104, 105]. Hybrid materials are 
classified into two categories: (1) class I hybrids that contain molecular entanglements, 
hydrogen bonding, and/or van der Waals forces; and (2) class II hybrids that also contain 
covalent bonding between components and are usually synthesized by functionalizing the 
polymer before introduction to the sol-gel. While these hybrids allow the generation of 
materials with highly tunable material properties, there are currently several 
disadvantages that must be considered when generating them [104, 106, 107]. The 
polymer chosen must be soluble in the sol-gel process (i.e., H2O), and have a suitable 
degradation rate. Additionally, the polymer may degrade at lower pHs (the isolectric 
point of silicic acid in water is 2, where the longest gelation time occurs) so the pH may 
need to be adjusted, resulting in quicker gelation times [104, 108]. Perhaps the biggest 
challenge of hybrid materials is the incorporation of calcium into the material. The 
calcium precursor for most sol-gel processing methods is calcium nitrate tetrahydrate 
(Ca(NO3)2∙ 4H2O) because it is highly soluble, but the nitrate byproducts are cytotoxic. 
This is usually addressed when the sol-gel materials are processed at high temperatures, 
which removes the nitrates, but the addition of polymers into the material does not allow 
for this [104, 109]. Therefore it is necessary to find a new source of calcium that will 
effectively be incorporated into the silica network, when generating these hybrid 
materials [104].  
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Figure 1.5. Stages involved in synthesis of TMOS-based silica sol-gel. Synthesis takes places in three 
distinct steps: hydrolysis, condensation, and poly-condensation. Post-synthesis processing can be used to 
further consolidate network structure.  
Silica Sol-Gel Bioactivity and Mineralization 
It is widely accepted that silica based bioglasses have osteogenic inducing 
properties. When the glass is exposed to body fluids or simulated body fluids, soluble 
silica is lost in the form of Si(OH)4 into the solution, breaking Si-O-Si bonds and creating 
Si-OH (silanols) at the material-solution interface. SiO2 condensates and repolymerizes at 
this surface, causing the migration of Ca2+ and PO43- which forms a CaO—P2O5 rich film 
on top of the SiO2 layer. This amorphous CaO—P2O5 film continues to grow through the 
incorporation of calcium and phosphates from solution, and is then crystallized by 
incorporation of OH- and CO32- anions to form a mixed hydroxyapatite (HA) layer 
(Figure 1.6). At this point biological growth factors can adsorb into the HA layer, 
contributing to the active differentiation of stem cells into osteoblasts. This dynamic 
interaction creates a strong bonding interface between the glass and its hard or soft tissue 
environment. In hard tissues a bond is formed as a result of the biological equivalence of 
the mineral phase of bone and the growing HA layer of the bioglass material. Soft tissue 
bonding occurs when collagen fibrils are chemisorbed on the SiO2 layer by electrostatic, 
ionic, and/or hydrogen bonding and HA is precipitated and crystallized onto collagen 
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fiber and material surfaces [84]. The character of the HA layer that is formed at the sol 
gel glass surface is dependent upon many factors including the composition of the sol 
material and the physical properties (i.e. roughness, topography, surface area) of the 
substrate surface. Previous work has shown that apatite formation on sol gel glasses 
composed of up to 90 mol% SiO2, is enhanced due to the large surface area available and 
the high concentration of silanol groups at the surface of the material. More recent work 
has been focused on determining the effect of additional elements to the composition of 
the bioglass including magnesium, potassium, aluminum, and iron on sol gel material’s 
bioactivity, with the majority of the focus being on the addition of different amounts 
calcium and phosphate to the silica network. However, the composition of a sol gel glass 
that is optimum for mineral formation is not known [110, 111]. 
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Figure 1.6. Overview of silica sol-gel bioglass bioactivity. (i) When silica based bioglasses are exposed 
to body fluids: (ii) soluble silica is lost in the form of Si(OH)4 into the solution, breaking Si-O-Si bonds and 
creating Si-OH (silanols) at the material-solution interface. (iii) SiO2 condensates and repolymerizes at this 
surface, causing the migration of Ca2+ and PO43- which forms a CaO—P2O5 rich film on top of the SiO2 layer. 
This amorphous CaO—P2O5 film continues to grow through the incorporation of calcium and phosphates 
from solution. (iv) Hydroxyl (OH-) and carbonate (CO32-) anions are incorporated to form a mixed 
hydroxyapatite (HA) layer. At this point biological growth factors can adsorb into the HA layer, contributing to 
the activation of differentiation of stem cells into osteoblasts. (v) The bioglass material and tissue create a 
bond due to the biological equivalence of the mineral phase of bone and the growing HA layer.  
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ION INFLUENCE ON OSTEOBLAST BEHAVIOR 
In addition to the ability to enhance biomineralization, dissolution ions (e.g. Si, 
Ca, P) in the surrounding dissolution medium as the bioglass network degrades have been 
found to influence the behavior of many tissue-specific cell types including, 
mesenchymal stem cells, osteoblasts, osteoclasts, fibroblasts, and endothelial cells; as 
well as bacteria (Figure 1.7) [4]. How these ions affect cell behavior is often tested with 
simultaneously using multiple ions, making it difficult to isolate the mechanisms by 
which the ions work to affect cell functions.    
Figure 1.7. Summary of biological effects due to ionic dissolution products of bioactive glasses. 
From Hoppe et al. with permission (see Appendix A) [4].  
Silica (SiO2) 
Osteoblasts exposed to silicate ions have been found to have increased collagen I 
production possibly through the posttranscriptional regulation of transforming growth 
factor β (TGFβ) [112, 113]. Silicon is also thought to play a role in collagen crosslinking 
through the regulation of prolyl-hydroxylase activity and the binding of 
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glycosaminoglycans (GAGs) to collagen, aiding collagen stabilization and preventing 
degradation [113, 114]. Osteoblast precursors cultured with silica ions have also been 
found to have increased adhesion, metabolic activity, and proliferation  [115, 116]. Silica 
ions have also been found to increase ALP activity and Runx2 and osteocalcin 
expression, indicating increased osteoblast differentiation [114, 117, 118]. Additionally, 
silica has been found to increase nodule formation (increased ECM mineralization) in 
osteoblast cultures due to its ability to facilitate nucleation of an apatite layer when 
exposed to body fluids [119].   
Calcium 
In bone, calcium not only is a main component of hydroxyapatite mineral, it acts 
as a signaling molecule to promote various osteoblast cell functions. During bone 
resorption osteoclasts direct calcium and phosphate release into the microenvironment, 
Increases in the local concentration of ions, specifically calcium, creates a gradient of 
chemical signals for preosteoblast migration and growth through a variety of mechanisms 
including the activation of calcium sensing receptors (CaSR/CaR), increasing 
intracellular calcium concentrations, and/or the extracellular signal-regulated kinase 
(ERK 1/2) pathway [120-122].  Calcium also plays a role in osteoblast proliferation and 
differentiation through calcium/calomodulin signaling [121]. However, the concentration 
range appropriate to ensure cell viability, while promoting cell differentiation and matrix 
maturation is still unclear. Several studies have found that treatment of 
preosteoblasts/osteoblasts with calcium ions at a concentration slightly higher than 
physiological increases cell proliferation, while at even higher levels cell differentiation 
and matrix mineralization is increased in both monolayer and three-dimensional culture. 
However, the elevated calcium levels also results in slight decreases in cell viability. 
Further, excessive calcium concentrations are known to be cytotoxic [5, 122, 123].   
Phosphate 
Phosphate, in addition to be the other main constituent of hydroxyapatite, is an 
important signaling molecule that helps to regulate osteoblast proliferation, 
transcriptional factors [Nrf2, HMGA1 and 2], signal transduction pathways [Fos-related 
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antigen-1 (Fra-1), extracellular signal-regulated kinase (ERK 1/2), calcyclin, A170)], 
plasma membrane and membrane transport factors [Pit-1, Annexin V], the secretion of 
bone-related proteins [matrix Gla protein (MGP)], and extracellular matrix cell adhesion 
protein [osteopontin] [124-128]. Additionally, cells treated with inorganic phosphate are 
found to exhibit decreased extracellular matrix protein gene expression [decorin, 
Tenascin C, periostin, thrombospondin, and collagens (I and III)] [125, 127]. However, 
the effects of phosphate are highly dose and time dependant, with high concentrations 
and exposure times increasing cell (osteoblast, chondrocyte, odontoblast) apoptosis in 
addition to ultimately contributing to these cells terminal differentiation [129, 130]. The 
use of phosphate releasing biomaterials is rare in the literature, possibly due to the lack of 
effective phosphate dosing methods to balance cell differentiation and apoptosis [12].  
NEBULIZER BASED SOL DEPOSITION OF SOL PARTICLES  
The novel sol vaporization system developed for this project uses nebulizer 
technology to generate vaporized sol particles at ambient conditions. A jet type-
compressed air nebulizer attached to a vaporization chamber (Figure 1.8A) aerosolizes 
the sol precursor solution, generating sol droplets with a large aggregate surface area that 
can easily be used to modify substrate surface topography and as a delivery vehicle for 
active molecules. This method allows for surfaces to be modified without the use extreme 
processing conditions, (i.e. temperature and harsh solvents), minimizing uncontrolled 
effects on substrate character as well as the functionality of inorganic and organic factors 
delivered via the sol-vapor. 
The system developed here uses a nebulizer to vapor deposit nano- and micro-
sized particles made of silica sol gel. In a jet-type nebulizer, compressed air flows 
through a narrow hole and collides with a colloidal solution from one or more inlets, 
generating vapor particles through momentum transfer (physical collision) (Figure 1.8B). 
The complex liquid break-up process is dependent upon the nozzle design and usually a 
combination of turbulent rupture of the instable liquid column and secondary droplet 
break-up [131, 132]. In its simplest form, the air flowing in to the nebulizer impinges 
directly on a solid jet of liquid.  Large droplets impact on the internal structure of the 
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nebulizer effectively reducing the mean droplet size and distribution. Only smaller 
droplets with less inertia can follow the flow of the compressed air and pass through the 
spray nozzle [133, 134]. Control over the size distribution of the particles produced is 
determined by the properties of the colloidal solution to a significant degree, with key 
variables including species concentration (H2O: alkoxide) and pH. The method developed 
here allows for a layer of sol particles to be deposited onto substrates, providing a large 
surface area, and creating a unique nano-structured surface topography and controlled 
modification of substrate surface properties.   
Figure 1.8. Schematic of vapor deposition system. (A) A jet-type nebulizer is attached to an air 
compressor and a vaporization chamber where sample is placed.  (B) When air flow is applied it enters 
nebulizer causing turbulence, breaking apart the sol solution and generating particles, which exit the 
nebulizer and enter the vaporization chamber. 
HYPOTHESES AND SPECIFIC AIMS 
The ultimate goal of tissue engineering is to restore and/or regenerate tissue 
structure and function, with typical approaches using engineered materials scaffolds. 
However, designing materials that will lead to a practical degree of recovery are difficult 
to construct, due in large part to the complexity of the dynamic chemical and physical 
microenvironment of a the native extracellular matrix. Cell behavior is influenced by the 
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chemical and its physical properties of a material. Therefore, development of 
biomaterials that utilize the relationship between material chemical and physical 
properties and cell response may provide a better platform for tissue regeneration. This 
project aims to develop vapor deposited silica sol gel particles as a novel cell instructive 
material system for use in composite bone and interfacial tissue engineering scaffolds. 
We hypothesize that these sol particles can be used as a means to: 1) deliver soluble 
bioactive factors to control cell behavior and mineral formation and 2) control 
chemical and physical properties of biomaterials to be used in orthopedic tissue 
engineering constructs. It is vital to understand how sol particle chemical and physical 
properties influence cell behavior in order to design material constructs that are capable 
of directing appropriate adhesion, proliferation, and differentiation of cells, with specific 
focus on osteoblasts. Understanding these relationships will allow us to develop a 
bioactive materials system to functionalize tissue engineering constructs, a focus of this 
research project, the specific aims of which are: 
 
Hypothesis 1- VAPOR DEPOSITED SOL PARTICLE CHEMICAL AND PHYSICAL PROPERTIES 
CAN BE CONTROLLED THROUGH CHANGES IN THEIR FORMULATION AND 
MANUFACTURING PARAMETERS. 
Specific Aim 1: Design sol formulations and fabrication methods for producing vapor 
deposited sol particles with controlled chemical and physical properties.  
The chemical (composition, stability, hydrophobicity) and physical (size 
distribution-morphology, roughness-topography) properties of vapor deposited sol 
particles are dependent upon sol formulation (pH, H2O:TMOS)  and manufacturing 
(deposition time, substrate composition) parameters. The goal of Aim 1 was to 
manufacture and characterize a series of particles whose chemical and physical properties 
are optimized to address controlling osteoblast behavior (bone formation).  
 
Hypothesis 2- VAPOR DEPOSITED SOL PARTICLES CAN BE USED AS DELIVERY VEHICLES 
FOR BIOACTIVE FACTORS AND INDUCE APATITE-LIKE MINERAL GROWTH.  
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Specific Aim 2: Generate sol particles capable of controlled release of inorganic 
molecules.  
Sol particles were modified by incorporating calcium and phosphate ions into the 
formulation process. Release kinetics and the functionality (mineral formation) of the 
incorporated molecules were determined. Additionally, how the incorporation of these 
molecules influences particle properties was assessed. The goal of Aim 2 was to assess 
particle potential to serve as controlled delivery vehicles for incorporated inorganic 
molecules and determine a specific set of parameters that facilitates biomimetic 
mineralization. 
 
Hypothesis 3- VAPOR DEPOSITED SOL PARTICLES CAN BE USED TO DIRECT BEHAVIOR 
OF OSTEOBLASTS THROUGH CELL-MATERIAL INTERACTIONS. 
Specific Aim 3: Determine the relationship between vapor deposited sol particle 
chemical-physical properties and osteoblast behavior.  
Osteoblast response (adhesion, proliferation, differentiation, and ECM 
development) in response to sol particles was assessed. Full characterization of the 
particles used will aid in determining the relationship between the material chemical-
physical properties and cell behavior. The goal of Aim 3 was to determine the particle 
formulation that best directs osteoblast behavior and ultimately aids in bone formation.  
Summary of Dissertation Chapters 
These aims will be discussed in a series of chapters written in the form of journal 
articles for publication. Chapter 2 will characterize the development of the sol particle 
vapor deposition system as a means to tailor material properties and sol formulation and 
manufacturing parameters affects on the particles (AIM 1). Chapter 3 will determine the 
ability to incorporate calcium and phosphate ions into the sol particles as well as the 
affects of these ions on particle properties and bioactivity (AIM 2). Chapter 4 will assess 
the ability of calcium-phosphate particles characterized in Chapter 3 to direct osteoblast 
behavior (AIM 3). Finally, Chapter 5 will present an overall summary and conclusions of 
the work from this dissertation, including an outline of the limitations of this work and 
proposed future directions.  
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CHAPTER TWO: DEVEOLOPMENT OF VAPOR 
DEPOSITED SOL-GEL PARTICLES1 
This chapter develops methods for generating vapor deposited sol particles as well as 
characterizing particle morphology, size distribution, and degradation and their affect on 
substrate surface hydrophobicity and roughness. Finally initial cell behavior in response 
to particles was assessed. The work in this chapter addresses Specific Aim 1. 
INTRODUCTION 
Surface modification and coatings for orthopedic and dental implants have been 
shown to promote osseointegration and mechanical fixation, increasing long-term implant 
effectiveness. In addition to surface roughening techniques, current methods of surface 
coating implants include plasma spraying, sputter deposition, electrophoretic deposition, 
biomimetic precipitation, and sol-gel coating [1-3]. Most established approaches have 
distinct shortcomings, especially those involving high energy plasma spraying or sputter 
coating [4-7]. These limitations include the introduction of surface porosity and residual 
stresses at the coating interface during processing, post-implantation concerns regarding 
delamination of applied coatings, and limitations in the size of treatable features [8-12]. 
For this reason, a significant research effort is aimed at improving the performance of 
implantable materials by better understanding and applying surface modification (e.g. 
chemistry, hydrophobicity, roughness, eluting coatings) to promote integration as well as 
resistance to infections. Many of these efforts include the surface modification of tissue 
engineering materials to make them bioactive in order to help restore and/or regenerate 
cell, tissue, and organ structure and function [13-15].  
Bioactive glasses are silica-based materials most prominently associated with 
orthopedic applications in both traditional implants as well as hard and soft tissue 
1 The material presented in this chapter was previously published in the Journal of 
Biomedical Materials Research Part A. [Snyder KL, Holmes HR, VanWagner MJ, 
Hartman NJ, Rajachar RM. Development of Vapor Deposited Silica Sol-Gel Particles for 
Use as a Bioactive Materials System. Journal of Biomedical Materials Part A 2012 (in 
press)] Reprinted with permission (see Appendix A). 
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engineering materials [16]. These matrices are porous networks obtained by the 
hydrolysis and condensation-polymerization of metallic alkoxides, most commonly 
silicon dioxide (SiO2) [17]. Sol-gel processing methods are becoming an increasingly 
popular approach for generating these glass materials because they offer simple methods 
to control composition and structure, making them suitable for a variety of biomedical 
applications [18, 19]. Sol-gel materials are produced when the solvent is removed from a 
colloidal suspension of precursors (sol) and the material is allowed to solidify (gel).  In 
the presence of water, the alkoxide groups are hydrolyzed, creating silanol groups and 
releasing alcohol. Condensation (polymerization) between silanol groups then occurs, 
creating Si-O-Si bonds. Extension of this reaction leads to a silica network with pores 
resulting from the removal of water and alcohol molecules.  As the polycondensation 
reaction continues, colloidal particles are formed in the solution. Over time the colloidal 
silica particles link together, increasing the viscosity of the solution, to form a solid three-
dimensional network. Due to their mild processing conditions, sol-gel materials can as 
also serve as controlled delivery vehicles for inorganic and organic small molecules (i.e. 
ions, drugs, proteins, antibodies, DNA) and even cells [20-25]. These materials have an 
inherently active influence on cell behavior modulated in part by ion release, surface 
chemistry, and topography. Dissolution products (e.g. Si, Ca, P ions) from these bioactive 
glasses can stimulate gene expression and promote osteogenesis and angiogenesis [26, 
27]. The exact nature by which these materials influence gene expression and promote 
tissue regeneration is not fully understood and warrants further exploration [28, 29].  
The aim of this work was to develop a novel nebulizer deposition system to 
generate vaporized sol-gel nanoparticles for the controlled surface modification of 
biomaterial substrates at ambient temperatures and pressures. More specifically, a jet 
type-compressed air nebulizer is used to aerosolize sol-based materials. In jet-type 
nebulizers, compressed air passes through a narrow hole and collides with a colloidal sol 
solution, generating vapor particles through momentum transfer (physical collision). The 
complex liquid break-up process is usually a combination of turbulent rupture of the 
instable liquid column and secondary droplet break-up [30, 31].  Large droplets impact 
on internal components of the nebulizer and only smaller droplets with less inertia can 
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follow the flow of the compressed air and pass through the spray nozzle [32, 33].  Control 
over the vaporized particle size distribution is dictated by the formulation properties of 
the colloidal sol-gel solution to a significant degree, with key variables being species 
concentration (H2O: alkoxide) and pH [17, 19]. The method developed here allows for a 
layer of sol particles to be deposited onto substrates, providing a large surface area, and 
creating a unique nano-structured surface topography and controlled modification of 
substrate surface properties. Conversely, most other sol-gel application methods 
consisting of dip, spin or spray coating, generate uniform thin film sol-gels [18, 34-36]. 
Unlike other common bioglass processing methods, the nebulizer-based approach also 
allows surfaces to be coated without the use of high temperatures or other extreme 
processing conditions that may alter the substrate surface or the character of delivered 
factors. This approach has the potential for easily creating complex multi-layered 
biomimetic coatings-incorporating a variety of small molecules, cells, and bone-like 
mineral to functionalize both traditional orthopedic-dental implants and tissue 
engineering constructs. A series of vapor deposited silica particles was generated to 
determine how changes of key formulation and manufacturing parameters (H2O: 
alkoxide, pH, deposition time, and substrate character) affect morphology, size 
distribution, and degradation behavior of particles as well as the overall surface 
properties (hydrophobicity and roughness) of the substrate. Additionally, we assessed the 
cellular biocompatibility by evaluating cell attachment in response to particles.   
MATERIALS AND METHODS 
Sol Preparation 
  The base sol solution used in these experiments was a 16:1 molar ratio of de-
ionized water and tetramethyl orthosilicate (TMOS; Sigma Aldrich). The solution was 
mixed in a 50ml centrifuge tube and catalyzed with 0.04M hydrochloric acid (HCl; 
Sigma Aldrich) at 2μl per gram of H2O/TMOS.  Catalyzed solutions were agitated for 20 
minutes to ensure that the solution was completely mixed. The clear homogenous 
material was allowed to rest for 30 minutes at 25°C before vaporization. 
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Vaporization System and Deposition 
Nebulizer-based vaporization was carried out using a jet-type nebulizer (Pari LC 
Plus, Allegro Medical) attached to a 500ml vaporization chamber (Figure 2.1). Sol 
solution was added to the nebulizer and connected to a compressed air supply with a 
0.2μm filter. Air pressure was maintained at 40psi during vaporization using an in-line 
pressure gauge. Samples were removed from chamber immediately after coating and 
allowed to fully polycondensate into a solid gel for 2 minutes. Samples were covered and 
stored for 3-7 days at 25°C until further use.     
Figure 2.1. Schematic of vaporization chamber and formation of vaporized sol particles. Vapor 
deposited sol particles are generated using H2O-tetramethyl orthosilicate (TMOS) catalyzed with HCl. (A) A 
jet-type nebulizer is attached to an air compressor and feeds into a substrate chamber. (B) Applied air flow 
(40psi) enters nebulizer inducing turbulent rupture of the sol, generating particles that exit the nebulizer and 
deposit on to the substrate.  
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Compositional Analysis 
 The chemical composition of the sol was determined using a series of five random 
energy dispersive X-ray spectrometry (EDS) measurements. Output peaks of interest 
include silicon and oxygen.  
Sol Formulation and Manufacturing Parameters 
 The major sol formulation and manufacturing parameters affecting the vapor 
particle morphology, size distribution, and degradation behavior are: H2O:TMOS molar 
ratio, solution pH, deposition time, and substrate character. Molar ratios (H2O:TMOS) of 
16:1 and 8:1 were used for analysis. For pH adjustments, sol solutions were adjusted to 
either 1 or 6 using HCl or NaOH, respectively, before vapor deposition from an original 
pH of 3. Sol particles were deposited on to non-tissue culture polystyrene (PS; VWR) for 
30, 60, and 90 seconds for both H2O:TMOS and pH experiments. To investigate the 
influence of substrate surface properties on particle morphology and size distribution, sol 
particles were deposited onto non-tissue culture treated polystyrene (PS), tissue culture 
treated polystyrene (TCPS; BD Bioscienes), and poly-L-lactide acid (PLLA; 
NatureWorks) films. TCPS and PLLA were chosen as substrates due to the differences in 
surface hydrophobicity (contact angle: untreated PS=73.59±1.94°, TCPS=41.08±1.91°, 
PLLA= 92.49±0.22°).  
Morphology and Size Distribution  
 Scanning electron microscopy images were used to make all particle morphology 
and size distribution measurements. Samples were sputter coated with Pt/Pd and imaged 
with a field emission scanning electron microscope (FE-SEM; Hitachi S-4700) under 
high vacuum conditions at an accelerating voltage of 1-5kV.  Quantitative measures of 
particle size distribution were made using a custom written MATLAB macro. All size 
distribution measurements were based on surface area measures for each individual 
particle.   
Degradation Behavior 
 The degradation behavior of the sol particle formulations was determined by 
depositing particles onto non-tissue culture PS (16:1 pH 3 for 30, 60, and 90s, 16:1 pH 1 
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for 60s). Silica matrix degradation over time (phenol-free Dulbecco’s Modified Eagle 
Medium (DMEM; Gibco) at 37°C) was assessed using a modified colorimetric 
molybdenum blue assay at 810nm.  Percentage silica matrix degradation was determined 
as a function of total silica deposited. 
Surface Hydrophobicity and Roughness 
Sol was prepared as described above and labeled with Rhodamine B (0.075µg/ml; 
Molecular Probes, Invitrogen) for image analysis. To evaluate the relationship that exists 
between the deposition time of particles and subsequent changes in surface properties, as 
well as demonstrate the ability to easily generate a single substrate that multiple regions 
of distinct surface character, a gradient was generated by vapor coating PLLA films (t= 
0.5, 1, 2, 5, and 15 minutes). PLLA was chosen as a model substrate because it would 
demonstrate the largest change in surface character with the deposition of sol particles 
due to its hydrophobic character. Samples were imaged using fluorescent microcopy, 
covered, and stored at room temperature until further analysis. The effect of vapor 
deposition on substrate surface hydrophobicity was determined using standard contact 
angle methods (sessile drop method). A Kruss G10 goniometer (Rame-Hart, Inc.) system 
was used to make all measurements. Droplets of di-H2O were added to the center of each 
sample; angle measurements at the liquid/substrate surface interface were taken and 
droplets were added until a plateau was reached (approximately 3-12µl total). All 
measurements were taken at 25°C. 
Comparative surface roughness of the PLLA film coated with a gradient of 
particles was determined using atomic force microscopy (AFM). A Nanoscope E (Digital 
Instruments) AFM system (constant deflection mode) with a micro-fabricated silicon 
nitride cantilever was used for imaging in air with a 5µm scanner. The surface 
topographical images of the PLLA film coated with vapor particles obtained by AFM 
were processed using Digital Instruments AFM software. RMS roughness (Rq) of the 
surface, defined as the standard deviation of the elevation (z values) within the given 
area, was determined within the image area (2.5µm). Images were taken at six different 
locations and the average RMS roughness was determined based on these images. 
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Measurements were taken at regions corresponding to 0.5, 1, and 2 minute deposition 
times on a sol gradient.  
Cell Attachment  
 Samples were generated by depositing sol solution (16:1 H2O:TMOS; pH 3) for 
60 and 90 seconds on to non-tissue culture PS. Samples were sterilized using ethylene 
oxide and rinsed three times with sterile phosphate buffered saline (PBS). MC3T3-E1 
Subclone 4 osteoblast progenitors (ATCC) were cultured directly on plates coated with 
particles or non-tissue culture PS as a control (1x104 cells/cm2) at 37°C and 5% CO2 in 
Minimal Essential Media (α-MEM; Hyclone) supplemented with 1% penicillin-
streptomycin (Mediatech) and 10% fetal bovine serum (FBS; Hyclone). Cells were also 
cultured on non-tissue culture PS using media that had been conditioned for 48 hours 
with particles deposited for 90 seconds at 37°C and 5% CO2. 
 At 24 and 48 hours, cells were fixed (4% paraformaldehyde), stained (TRITC-
conjugated Phalloidin and 4',6-diamidino-2-phenylindole, DAPI; Molecular Probes, 
Invitrogen), and imaged (Olympus BX51 microscope). Cell attachment was determined 
through direct cell counts and normalized to control samples with untreated media. To 
determine whether particle degradation affected culture media with time, pH 
measurements were made at both 24 and 48 hours. 
Statistics 
 All experiments were performed in triplicate. Data was analyzed for significance 
using an analysis of variance (ANOVA) and a Tukey’s post-hoc test for pairwise 
comparison.  Statistical significance defined as a p-value less than 0.05 (p<0.05). Error 
bars in text and graphs represent standard error of the mean (±SEM). 
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RESULTS 
Effect of Formulation and Manufacturing Parameters on Particle Morphology and 
Size Distribution  
H2O:TMOS MOLAR RATIO 
 Silica nano- and micro-particles were generated using the vaporization chamber. 
EDS analysis of the particles showed a percent atomic composition of 43.47±1.76 silicon 
and 54.88±1.30 oxygen with trace amounts of carbon registering from the underlying 
polystyrene plate.  The effect of H2O:TMOS molar ratio on sol particle morphology and 
size distribution was determined. Particles were generated from solutions with 
H2O:TMOS molar ratios of 16:1 or 8:1 (pH 3), deposited onto PS for 30, 60, and 90 
seconds, and imaged using FE-SEM (Figure 2.2A). At a molar ratio of 8:1 average 
particle area (µm2) did not change significantly with deposition time [0.136±0.01 t=30s, 
0.114±0.01 t=60s, 0.130±0.02 t=90s; p≥0.5] and the particle size distributions (Figure 
2.2B) were also consistent for all deposition times. At a molar ratio of 16:1 the average 
particle area (µm2) changed significantly with time [0.620±0.13 t=30s, 0.076±0.01 t=60s, 
0.329±0.06 t=90s; p<0.0001] and the size distributions (Figure 2.2C) also varied with 
deposition time. At each deposition time the average particle area for the 8:1 and 16:1 
particles was significantly different; the average area was larger for 16:1 particles at 30 
and 90 seconds (p<0.0001) and 8:1 particles at 60 seconds (p<0.002; Figure 2.2D). 
SOL PH 
 To investigate the effect of pH on particle morphology and size distribution, the 
pH of sol solutions (16:1 H2O:TMOS) was adjusted from 3 to 1 or 6 before vapor 
deposition onto PS for 30, 60, and 90 seconds. FE-SEM images show particle 
morphologies at 30, 60, and 90 seconds (Figure 2.3A). Particles generated from solutions 
with an unadjusted pH 3 had average particle areas (µm2) [0.620±0.13 t=30s, 0.076±0.01 
t=60s, 0.329±0.06 t=90s; p<0.0001] and size distributions (Figure 2.3B) that varied at 
each deposition time. Particles generated from solutions with an adjusted pH of 1 had 
average particle areas (µm2) and size distributions (Figure 2.3C) that were similar 
regardless of deposition time, with the average particle area being significantly smaller at 
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90 seconds than the average area at 60 seconds [0.052±0.01 t=30s, 0.058±0.004 t= 60s, 
0.040±0.001 t=90s; p<0.0001]. Though the average area (µm2) of particles generated 
from pH 6 solutions increased with deposition time, these changes were not statistically 
significant [0.133±0.05 t=30s, 0.296±0.08 t=60s, 0.339±0.07 t=90s; p=0.1] and particles 
were much more irregular in shape than those generated from solutions with pH equal to 
1 or 3 (Figure 2.3A). The size distributions of the pH 6 particles also varied with 
deposition time (Figure 2.3D). At 30 seconds the average particle area was significantly 
different for all three particle formulations with pH 1 particles being smallest and pH 3 
particles being largest (p<0.02). At 60 seconds, pH 1 and 3 particles were significantly 
smaller than pH 6 particles (p<0.0001), and at 90 seconds the average particle area of pH 
1 particles was significantly smaller than pH 3 and pH 6 particles (p<0.0001; Figure 
2.3E). 
SUBSTRATE 
The effect of substrate surface properties on particle morphology and size 
distribution was also investigated (16:1 H2O:TMOS, pH 3). In addition to PS, particles 
were deposited onto TCPS and PLLA (Figure 4A). Particles deposited onto TCPS had 
average particle areas (µm2) that were significantly smaller at 60 seconds than 30 or 90 
seconds [0.123±0.02 t=30s, 0.044±0.01 t=60s, 0.104±0.02 t=90s; p<0.01]. The size 
distribution of particles deposited onto TCPS also varied with deposition time (Figure 
2.4C). Particles deposited onto PLLA maintained a similar size distributions regardless of 
deposition time (Figure 2.4D),  though the average particle areas (µm2) were 
significantly different from each other at each deposition time [0.138±0.02 t=30s, 
0.049±0.002 t=60s, 0.083±0.01 t=90s; p<0.0001]. Similar to particles deposited onto PS, 
particles on TCPS and PLLA had largest average particle areas at 30 seconds, a decrease 
in size at 60 seconds and a subsequent increase at 90 seconds. At 30 and 90 seconds the 
average area of particles deposited onto PS was significantly larger than that of particles 
deposited on to TCPS or PLLA (p<0.0001). At 60 seconds the average particle size was 
not significantly different on any of the substrates (p=0.6; Figure 2.4E).  
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Figure 2.2. Effect of H2O:TMOS on particle morphology and size distribution. Sol solutions (pH 3) with H2O:TMOS of 8:1 and 16:1 were vapor deposited 
on to PS for 30, 60, and 90 seconds, (A) imaged using FE-SEM (scale bar = 10µm) and the area-based size distribution of particles was analyzed using a 
MATLAB macro [(B) 8:1 (C) 16:1]. (D) Average particle area did not change with increasing deposition time for 8:1 particles. Average area of 16:1 particles was 
initially largest, decreased at 60 seconds followed by an increase at 90 seconds. A molar ratio of 16:1 produced larger particles at 30 and 90 seconds while at 
60 seconds a ratio of 8:1 yielded relatively larger particles. All comparisons were made using ANOVA, p-values < 0.05 were considered significant. Values with 
different letters/numbers are significantly different-- letters compare different deposition times in same group (rows) and numbers compare different groups 
within same deposition time (columns). Error bars represent ±SEM.   
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Figure 2.3. Effect of solution pH on particle morphology and size distribution. The pH of sol solutions (16:1 H2O:TMOS) was adjusted from 3 to 1 or 6, 
deposited on to PS for 30, 60, and 90 seconds, (A) imaged using FE-SEM (scale bar = 10µm), and the area-based size distribution was analyzed using a 
MATLAB macro [(B) pH 3, (C) pH 1, (D) pH 6]. (E) Particles generated from a solution with a pH of 3 produced the largest average particles at 30 seconds with 
a decrease in particle area at 60 seconds and an increase at 90 seconds. Solutions with a pH 1 generated particles with average areas that decreased at 90 
seconds. Average particle area did not change in pH 6 particles regardless of deposition time.  At 30 seconds, pH 1 particles generated the smallest average 
particles and pH 3 the largest. At 60 seconds, pH 6 particles were larger than pH 1 and pH 3 particles, and at 90 seconds the average area of pH 1 particles is 
smaller than pH 3 and pH 6 particles. All comparisons were made using ANOVA, p-values < 0.05 were considered significant. Values with different 
letters/numbers are significantly different-- letters compare different deposition times in same group (rows) and numbers compare different groups within same 
deposition time (columns). Error bars represent ±SEM. 
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Figure 2.4. Effect of substrate on particle morphology and size distribution. Sol solutions (16:1 H2O:TMOS; pH 3) were deposited on to PS, TCPS, and 
PLLA  for 30, 60, and 90 seconds, (A) imaged using FE-SEM (scale bar = 10µm), and the area-based size distribution was analyzed using a MATLAB macro 
[(B) PS, (C) TCPS, (D) PLLA]. (E) Analysis of the average particle area showed that on all substrates at 30 seconds deposition time, the average particle area 
was largest, with a decrease in average particle area at 60 seconds and a subsequent increase in particle area at 90 seconds.  The average particle area of 
particles deposited on to PS was larger than those deposited onto TCPS and PLLA at all deposition times. All comparisons were made using ANOVA, p-values 
< 0.05 were considered significant. Values with different letters/numbers are significantly different-- letters compare different deposition times in same group 
(rows) and numbers compare different groups within same deposition time (columns)  Error bars represent ±SEM    
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Figure 2.5. Effect of deposition time and pH on degradation of sol particles. Sol solutions with 
H2O:TMOS of 16:1 were vapor deposited onto PS for 30, 60, and 90 seconds. Additionally particles with 
an adjusted pH of 1 were vapor deposited onto PS for 60 seconds. (A) Silica matrix degradation over time 
in phenol-free DMEM at 37°C was determined by measuring dissolved Si(OH)4 using a modified 
molybdenum blue assay at 810 nm. pH 3 30s particles were fully degraded by day 4 and pH 1 60s 
particles were fully degraded by day 5, while at day 10 pH 3 60 and 90s particles were 97.38±2.62%  and 
98.84±1.16% degraded, respectively.  Percent degradation of pH 3 30 second and pH 1 60 second 
particles was significantly different than pH 3 60s and 90 second particles during the first three days. (B) 
Total silica content on the plates (mg/cm2) shows an increase in silica deposited onto places increasing 
with deposition time. All comparisons were made using ANOVA, p-values < 0.05 were considered 
significant (* indicates statistical significance). Error bars represent ±SEM.   
 
Effect of Formulation Parameters on Particle Degradation Behavior 
 The effect of deposition time and solution pH on particle degradation behavior 
was determined. Particles with a pH 3 (16:1 H2O:TMOS) were deposited onto PS 30, 60, 
and 90 seconds or an adjusted  pH of 1 for 60 seconds. The amount of silica degraded 
over time in DMEM at 37°C was determined as a function of total silica deposited using 
a colorimetric silica assay. Though the amount of silica deposited (mg/cm2) onto the plate 
increases with deposition time the changes are not significant (p=0.07; Figure 2.5B).  
Particles deposited for 30 seconds (pH 3) were fully degraded by day 4 and pH 1 60s 
particles by day 5, while pH 3 60s and pH 3 90s particles were 97.38±2.62% and 
98.84±1.16% degraded, respectively by day 10.  The percent degradation for pH 3 30s 
particles was significantly higher than pH 3 60s particles for days 1-3 and pH 3 90s 
particles at days 1 and 2 (p<0.04). Particles with an adjusted pH of 1 (60s) degraded 
significantly faster than pH 3 60s particles during the first two days only (p=0.04; Figure 
2.5A).  
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Effect of Particle Deposition on Substrate Surface Character 
 Contact angle analysis was used to determine changes in surface hydrophobicity 
with increasing sol deposition (Figure 2.6B). The average contact angle significantly 
decreased with increasing vapor deposition time [92.49±0.22° at t=0 to 73.92±1.33° at 
t=15min; p<0.0001]. The overall trend showed that increasing vapor deposition caused a 
decrease in contact angle, indicating that the surface hydrophobicity decreases with vapor 
deposition time [88.38±1.13° t=1min, 81.11±0.82° t=2min]. However, the contact angle 
did increase at 5 minutes (85.68±1.51°) before decreasing again. Surface roughness 
measurements on sol gradient showed that average surface roughness (RMS roughness) 
increased with increased vapor deposition time [0.22±0.05nm at t=0 to 303.4±42.83nm at 
t=2min; Figure 2.6C]. There were significant increases in surface roughness at 
deposition times of 1 and 2 minutes when compared to the uncoated PLLA films 
(p<0.003). Roughness measurements at deposition times greater than 2 minutes were not 
feasible due to the resolution limits of AFM roughness measurements.  
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Figure 2.6. Effect of sol particles on surface wettability and roughness. (A) A sol gradient was generated on a PLLA film using a simple masking approach 
with vaporization time of Rhodamine B labeled sol ranging from 1-15 minutes and imaged using fluorescent microscopy. (B) Sessile drop contact angle analysis 
on a sol gradient was used to determine the relative hydrophobicity change on PLLA substrate with increasing particle deposition. The contact angle measures 
showed a general decrease with increasing vapor deposition indicating the surface hydrophobicity is decreasing.  (C) Comparative surface roughness changes 
along gradient using AFM micrographs and analysis of 2.5μm area showed an increased surface roughness with increasing deposition time. Measurements over 
two minutes were not possible using AFM approach. All comparisons were made using ANOVA, p-values < 0.05 were considered significant. Values with 
different letters are significantly different. Error bars represent ±SEM.   
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Osteoblast Response to Sol Particles 
 MC3T3 preosteoblasts were cultured on non-tissue culture PS dishes that were 
coated with particles (16:1 H2O:TMOS; pH 3) for 60 (Figure 2.7C,G), 90 seconds 
(Figure 2.7D,H), and on plain non-tissue culture PS dishes using either untreated culture 
media (Figure 2.7A,E)  or culture media that had been conditioned for 48 hours with 
particles deposited for 90 seconds (Figure 2.7B,F) for 24 or 48 hours. At 24 hours, cell 
attachment on substrates cultured with conditioned media and those coated with sol 
particles for 60 and 90 seconds showed higher attachment compared to the control 
cultures, with significantly higher attachment on 90s cultures [attachment=1.00±0.16 
control, 1.57±0.24 conditioned media, 1.59±0.22 t=60s, 1.97±0.29 t=90s; p=0.03]. At 48 
hours, cell attachment on substrates using conditioned media and those coated with sol 
particles for 60 and 90 seconds was still higher than control cultures with significantly 
higher attachment at 60s [attachment=1.00±0.11 control, 1.34±0.11 conditioned media, 
1.88±0.24 t=60s, 1.37±0.15 t=90s; p=0.002; Figure 2.7I]. To determine whether the sol 
particles affected media pH during culture as the particles degraded and released ions, 
media pH was recorded at each time point. No significant differences were found 
between the pH of control culture media and those of conditioned media or cultures 
containing particles (p=0.2; data not shown). 
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Figure 2.7. Osteoblast response to sol particles. MC3T3 preosteoblasts were cultured on non-tissue culture PS  dishes that have been vapor coated with 
sol particles (16:1 H2O:TMOS; pH 3) for (C,G) 60 or (D, H) 90 seconds or on plain non-tissue culture PS dishes using either (A,E) untreated culture media or 
(B,F) culture media that had been conditioned with particles (deposited for 90 seconds) for 48 hours. At (A-D) 24 and (E-H) 48 hours the cells were stained 
using TRITC-conjugated Phalloidin and DAPI and cell attachment was assessed (scale bar = 200µm). (I) Cell attachment on plates coated with sol particles 
had higher attachment at both 24 and 48 hours compared to control cultures that used untreated culture media (significant differences 60 seconds at 24 hours 
and 90 seconds at 48 hours). All comparisons were made using ANOVA, p-values < 0.05 were considered significant (* indicates statistical significance). Error 
bars represent ±SEM.   
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DISCUSSION 
 There are inherent limitations in current techniques for the surface modification of 
biomaterials; this work focused on the development of a simple, rapid, and effective 
method to generate silica particles for the surface modification of biomaterials without 
extreme processing conditions (i.e. high temperatures and pressures and harsh solvents) 
used in other sol-gel manufacturing methods. Particle morphology, size distribution, and 
degradation behavior was characterized, and controlled by adjusting key manufacturing 
parameters including H2O:TMOS molar ratio, pH, deposition  time, and substrate. 
Changes in surface properties (hydrophobicity and roughness), the ability to incorporate 
apatite specific ions, and cell behavior in response to particles was also determined.   
 The amount of water available for the hydrolysis reaction has a dramatic influence 
on gelation time of a sol-gel solution. For lower water contents (H2O:TMOS<7-8:1) an 
increase in the amount of water available decreases the gelation time. At H2O:TMOS>7-
8:1, the increase in water creates a dilution effect, with the gelation time increasing with 
the quantity of water [17, 34]. Molar ratios of 8:1 and 16:1 were used to determine the 
effect on particle morphology and size distribution. Solutions with an 8:1 ratio produced 
particles that were consistently the same size (size distributions and average particle size) 
regardless of deposition time. Solutions with a 16:1 ratio produced particles whose 
average area peaked at 30 seconds; decreased at a deposition time of 60 seconds and 
subsequently increased again at 90 seconds. The size distributions of the 16:1 particles 
showed similar trends at each deposition time. These differences may be attributed to 
gelation behavior. In 8:1 particles, deposition time was found to be irrelevant, whereas in 
the 16:1 particles, deposition time has an effect on the average particle size and 
distribution. Elevated relative water content may increase the gelation time of particles, 
causing deposition time to play a larger role in resultant particle size, with solutions 
containing a lower water content, whose gelation rates would be faster.   
 It is widely accepted that the polymerization of sol-gels is highly pH dependant. 
In the polymerization reaction the point of zero charge (where the surface charge is zero) 
and the isoelectric point (the point where the electrical mobility of the silica particles is 
zero) fall between pH 1 and 3, producing slower gelation times. Between pH 2 and 6 the 
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gelation rate is proportional to the concentration of OH-, steadily decreasing the gelation 
time with increasing pH. Solutions become most unstable (and therefore gelling most 
quickly) at pH 5-6. Below pH 2, where the solubility of silica is low, solutions are 
considered metastable resulting in gelation times that are relatively long and 
polymerization rates are proportional to the concentration of H+ [17, 34]. The original pH 
of the sol gel solutions was 3. Adjustments of the solution to pH 1 and 6 were chosen due 
to the limitations of the system: at pHs lower than 1 solutions did not gel at all and at pHs 
higher than 6 solutions gelled too quickly to be used in the nebulizer. Solutions with a pH 
of 3 were stable enough to be used in the vaporization system but gelled quickly enough 
that deposition time influenced particle size. Particles generated from pH 1 solutions 
produced particles with very small average particle sizes and similar size distributions at 
all times points. This is most likely due to the low viscosity and long gelation time of the 
colloidal solution. Solutions with a pH of 6 produced particles that had irregularly shaped 
morphologies and particles sizes that were inconsistent from sample to sample due the 
rapid gelling rate of the solution. The rate of polymerization of a sol solution is dependent 
upon the pH and therefore will have the largest impact on particles at pH values between 
2 and 6, where the gelation rate of the solution is the most suitable for use in the 
deposition system. 
 The underlying substrate will always play a role in dictating the outcome of any 
surface modification approach, due to substrate surface chemistry, hydrophobicity 
(wettability), and roughness. Particles were vapor deposited onto three distinct substrates 
(PS, TCPS, PLLA) to demonstrate this. On all substrates, particles show a trend with an 
average area largest, decreasing, and then subsequently increasing again at 30, 60, and 90 
seconds deposition time, respectively. However, at all three deposition times the average 
particle area was always significantly larger on PS than on TCPS or PLLA. A fraction of 
the particles deposited on to PS were able to aggregate and form larger particles before 
gelation, resulting in larger average particle areas. Plasma treatment of polystyrene 
(TCPS) decreases the hydrophobicity of the surface (contact angle of 41.08±1.91° 
compared to 73.59±1.94° of untreated PS), and generates a surface containing more 
exposed oxygen groups. This may allow for better adsorption of proteins such as 
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vitronectin, providing a surface that is more conducive to cell attachment than untreated 
PS.[37-39] This change in surface chemistry interacts with the sol particles, which 
generates smaller particles than on PS. The highly hydrophobic nature of the PLLA 
surface (contact angle 92.49±0.22°) may essentially isolate the hydrophilic sol particles 
as they are deposited onto the PLLA surface preventing them from aggregating before 
they gel, resulting in many small particles at all deposition times [40]. The surface 
properties of a substrate will help dictate the particle size due to the interactions between 
the substrate and the particles. 
The duration that cells are exposed to a material will determine to what extent it 
will influence their behavior. Therefore, the degradation rate of a material will 
significantly impact its overall effectiveness as an instrument to direct cell behavior.  The 
degradation behavior of particles generated from 16:1 pH 3 (deposition time 30, 60, and 
90s) and 16:1 pH 1 (deposition time 60s) solutions was determined over 10 days. 
Particles deposited for 30s degraded most quickly, most likely due to the increased 
effective surface area available for degradation, compared to those deposited for 60 or 
90s when particles have time to aggregate and thereby reducing the effective surface area. 
pH 1 60s particles also degraded more quickly than their pH 3 counterparts even though 
the silica content on the plates was similar. This is could be due to the differences in the 
networking in the pH 1 particles during the extended gelation time. The differences in 
degradation between particle groups are largest within the first three days, indicating that 
particles will have the greatest impact on cell behavior during this time period. Substrate 
surface character can impose a strong influence on initial protein adhesion, cell viability 
and attachment (nanoseconds to days), and consequently influence long-term cell 
behavior including cell spreading, proliferation, differentiation, and extracellular matrix 
production [41]. 
 The surface properties of a material can be used to direct many aspects of cell 
behavior including attachment, proliferation, and differentiation depending on the cell 
type. Specifically, osteoblasts and osteoblast precursors have been found to respond to 
surface hydrophobicity in a time dependant manner. Initial cell attachment and spreading 
have been found to be higher on moderately hydrophilic surfaces than on hydrophobic 
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surfaces [42]. In general, osteoblasts have better adhesion, larger cell spreading, higher 
proliferation, and enhanced differentiation on substrates with an increased surface 
roughness. Many studies have shown that surface roughened implants promote 
osseointegration better than their smooth counterparts [43, 44]. In this work it was 
demonstrated that increasing vapor deposition of particles onto substrates caused a 
decrease in contact angle, indicating that the surface became more hydrophilic. Vapor 
deposition of sol particles also showed the ability to increase the surface roughness of a 
material. Furthermore, a unique surface topography is created when sol is deposited onto 
substrates. This random surface topography generated by the deposition of sol particles 
onto substrates may further help to promote osteoblast differentiation. Dalby et al. 
showed that mesenchymal stem cells cultured on substrates containing nano-pit arrays 
differentiate into either fibroblasts or osteoblasts depending on the order/disorder of the 
arrays. Cells cultured on highly ordered arrays resulted in cells with fibroblastic 
appearances, while cells cultured on more irregular arrays resulted in cells with an 
osteoblastic morphology and gene expression [45]. Vapor deposited sol particles allow 
for the modification of a material’s surface properties in a way that could aid in directing 
osteoblast behavior by increasing surface hydrophilicity and roughness, as well as 
generating a unique surface topography. 
 The ultimate goal of this work is to be able to use these particles in combination 
with other conventional biomaterials such as orthopedic and dental implants and tissue 
engineering scaffolds to better direct cell behavior including attachment, proliferation, 
and differentiation via cell-material interactions. Vapor deposition of sol particles onto 
non-tissue cultures PS substrates increased attachment of preosteoblasts in comparison to 
controls cultured on PS alone, potential indication their ability to increase cell 
proliferation. Cells cultured with no particles and media that had been conditioned with 
particles (containing silica sol dissolution products) also showed increased cell 
attachment, though the effect was not significant (p=0.45). This indicates that increases in 
cell attachment can be attributed in part to both the modification of the physical 
properties of the PS (wettibility, roughness, topography) as well as the chemical 
composition, specifically silica. It is important to note that degradation products did not 
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significantly change pH in culture. This surface modification method allows for the 
deposition of particles whose chemical and physical properties cause an  increase in cell 
attachment onto substrates, indicating the potential of further directing osteoblast 
behavior.  
CONCLUSION 
 This work demonstrates the use of a simple and novel system for the surface 
modification of materials through the vapor deposition of silica sol-gel particles. The 
morphology, size distribution, and degradation of these particles can easily be controlled 
through key formulation and manufacturing parameters including sol H2O:TMOS molar 
ratio and pH, as well as deposition time and substrate character. These particles can be 
used to alter the overall surface properties of a material including surface hydrophobicity, 
roughness, and topography. Furthermore, these particles increase initial cell attachment 
of preosteoblasts compared to unmodified control substrates, demonstrating their 
potential to aid in promoting cell attachment. Current work is focused on how different 
formulations of particles can promote osteoblast attachment, proliferation, and 
differentiation using quantitative gene expression measures. 
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CHAPTER THREE: CALCIUM-PHOSPHATE 
SILICA SOL PARTICLES FOR BIOACTIVE 
SURFACE MODIFICATION2 
This chapter expands on the methods for generating vapor deposited particles developed 
in Chapter 2 by incorporating biologically active elements, calcium and phosphate ions, 
into the particles. The work in this chapter addresses Specific Aim 2. 
INTRODUCTION 
Bioactive glasses and other silica based materials are becoming increasingly 
popular for use in biomedical applications due to their inherent biocompatibility; ability 
to actively influence cell driven processes including osteogenesis and angiogenesis; and 
enhanced antimicrobial character [4]. These glasses can be generated using a variety of 
methods, with two of the most common being melt derived and sol-gel processing. Sol-
gel approaches have an advantage over traditional melt methods because they allow for 
mild processing conditions (ambient temperature-pressure and biologically tolerated by-
products) and simple methods to control composition and structure of the material. 
Because of this sol-gel based materials have been used as delivery vehicles for various 
inorganic and organic small molecules including ions, drugs, enzymes, antibodies, 
growth factors, DNA, and even cells [7, 89-95].   
The main disadvantage of sol–gel synthesis over the melt process is that it is 
difficult to obtain crack-free bioactive glass monoliths (diameters >1 cm) due to cracking 
during drying. The cracking can result in part from the large shrinkage that occurs during 
drying; and the evaporation of the liquid by-products of the condensation reaction. 
During drying, vapor must travel from within the gel to the surface via the interconnected 
pore network. This can cause capillary stresses within the pore network and therefore 
cracking. For small cross-sections, such as in particles, drying stresses are small, as the 
path of evaporation is short and the stresses are accommodated. For monolithic objects, 
the path from the center of the monolith to the surface is long and tortuous, and the 
1 The material presented in this chapter is in preparation for submission to the Journal of Biomedical 
Materials Research Part A. [Snyder KL, Holmes HR,  Rajachar RM]. 
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drying stresses can introduce catastrophic fracture. Increasing pore size and obtaining 
pores with a narrow distribution reduce tortuosity [107].  
When exposed to body fluids bioglass materials generate a dynamic bio-reactive 
surface microenvironment that can act as a strong bonding interface between the glass 
and a hard or soft tissue environment. Upon exposure, soluble silica in the form of 
Si(OH)4 is lost in solution, breaking Si-O-Si bonds and creating Si-OH (silanols) at the 
material-solution interface. SiO2 condensates and re-polymerizes at this surface, causing 
the migration of Ca2+ and PO43- --forming a CaO—P2O5 rich film at the SiO2–aqueous 
interface. This amorphous CaO—P2O5 film continues to grow incorporating calcium and 
phosphate from solution, which is then crystallized by incorporation of OH- and CO32- 
anions to form a mixed hydroxyapatite (HA) layer. At this point biological growth factors 
can adsorb into the HA layer, contributing to activate differentiation of stem cells into 
osteoblasts (Table 3.1-see also Figure 1.6). This dynamic interaction creates a strong 
bonding interface between the glass and its hard or soft tissue environment. In hard 
tissues a bond is formed due to the biological equivalence of the mineral phase of bone 
and the growing HA layer of the bioglass material. Soft tissue bonding occurs when 
collagen fibrils are chemisorbed on the SiO2 layer by electrostatic, ionic, and/or hydrogen 
bonding and HA is precipitated and crystallized onto collagen fibers and material 
surfaces [87].  
Table 3.1. Overview of apatite formation on bioglass material upon exposure to body fluids.  
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The HA layer that is formed at the sol-gel glass surface is dependent upon many 
factors including the ion concentration and pH of the solution medium as well as the 
composition of the sol material and its physical properties (i.e. roughness, topography, 
surface area, pore size) [138-142]. Recent work has been focused on determining the 
effect of additional elements (including calcium, phosphate, magnesium, potassium, 
aluminum, cobalt, boron, vanadium, zinc, strontium, iron and fluorine) to the 
composition of the bioglass and bioactivity, with the majority of the focus being on the 
addition of calcium and phosphate to the silica network. These elements are known 
network modifiers to the architecture of the silica network, and consequently the 
composition of mineral phase (Figure 3.1) [113, 114, 142, 143]. High calcium content in 
bioglass has been found to increase pore volume and decrease surface area of the 
material, thus increasing the amount of calcium released, which leads to increased apatite 
formation [141, 144-146]. While phosphate is not necessary in glasses for apatite 
formation, when the amount of P2O5 is added in less than 6 mol%, it increases the surface 
area and decreases pore diameter and pore volume, as well as induces mineral crystal 
growth more quickly than glasses without it [144, 147-149].  However, the composition 
of a sol-gel glass that is optimum for mineral formation is not known and remains a topic 
of exploration [4, 113, 114]. 
The goal of this work was to successfully incorporate calcium and phosphate ions 
into vapor deposited silica sol-gel particles (three different formulations). The 
morphology and size distribution of the calcium-phosphate sol particles was determined 
as well as how these particles affected overall substrate hydrophobicity. The silica matrix 
degradation and ion release character was also determined. Finally, the ability for these 
particles to induce apatite mineral formation was determined.  
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Figure 3.1. Network modifiers. Incorporation of additional ions (i.e., calcium, phosphate magnesium, 
potassium) into a sol-gel will modify the silica network architecture and therefore have a resulting effect on 
the composition of the mineral formed. 
MATERIALS AND METHODS 
Sol Preparation and Vapor Deposition 
 The base compositions of the sol solutions used in these experiments was a 16:1 
molar ratio of de-ionized water to tetramethyl orthosilicate (TMOS; Sigma Aldrich). The 
solution was catalyzed with 0.04M hydrochloric acid (HCl; Sigma Aldrich) at 2μl per 
gram of TMOS/di-H2O.  Catalyzed solutions were agitated for 20 minutes to ensure that 
the solution was completely mixed. The clear homogenous solution was then allowed to 
rest for 30 minutes at 25°C, where the solution was then stable for vaporization. 
Nebulizer-based vaporization was carried out using a jet-type nebulizer (Pari LC Plus, 
Allegro Medical) attached to a 500ml polycarbonate bottle whose bottom had been 
removed and served as the vaporization chamber. The nebulizer containing the sol was 
connected to a compressed air supply with a 0.2μm airline filter. Sol was vapor deposited 
onto non-tissue culture polystyrene (PS) for 60 seconds at 40psi, maintained using an in-
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line pressure gauge.  Samples were removed immediately after deposition and the sol was 
allowed to fully polycondensate into a solid gel for 2 minutes.  Samples were covered and 
stored at 25°C for 3-7 days until further use.     
Calcium and Phosphate Incorporation into Sol 
 Calcium (Ca) and phosphate (P) ions were incorporated into solutions just before 
vapor deposition by adding 1M calcium chloride (CaCl2; Sigma Aldrich) and 1M triethyl 
phosphate (TEP; Sigma Aldrich) in three different formulations  (v/v%): 5% Ca/5% P, 
25% Ca/25% P, and 25% Ca/5% P.  
Size Distribution and Morphology  
 Scanning electron microscopy was used to characterize the morphology and size 
distribution of the sol particles. All samples were sputter coated with Pt/Pd (5nm) and 
imaged with a field emission scanning electron microscope (FE-SEM; Hitachi S-4700) 
under high vacuum conditions at accelerating voltages of 1-5 kV. Quantitative measures 
of particle size distribution were made using a custom written MATLAB macro. All size 
distribution measurements were based on surface area measures for each individual 
particle.   
Surface Hydrophobicity  
The effect of vapor deposition of Ca/P sol particles on substrate surface 
hydrophobicity was determined using standard contact angle methods (sessile drop 
analysis) at 25°C. A Kruss G10 goniometer (Rame-Hart, Inc.) system was used to make 
all measurements. Droplets of di-H2O were added to the center of each sample in 
succession; angle measurements at the liquid/substrate surface interface were taken and 
droplets were added until a plateau was reached (approximately 3-12µl total).  
Degradation Behavior 
 The degradation behavior of the silica matrix over 7 days in phenol-free media at 
37°C was determined using a modified colorimetric tin chloride-molybdenum blue silica 
assay at 810nm. Percentage silica matrix degradation was determined as a function of 
total silica deposited. 
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Mineral Composition and Morphology 
 Ca/P particle ability to induce stabile mineral crystal formation was assessed by 
vapor depositing sol solutions onto PS plates for 60 seconds and incubating in simulated 
body fluid (SBF) at 37°C for 7 days. Control groups consisted of PS plates containing no 
particles and PS plates coated with sol particles containing no calcium or phosphate for 
60 seconds. SBF solutions were changed every 2 days to replenish ions. Mineral crystal 
morphology and composition were analyzed with FE-SEM imaging and using energy 
dispersive X-ray spectrometry (EDS) compositional analysis, respectively. Output peaks 
of interest included calcium and phosphate and the calcium to phosphate ratio (Ca:P) of 
the mineral was determined.  
 3-D Application of Vapor Deposition Methods 
 To demonstrate the practical application of these particles for use in orthopedic 
tissue engineering applications, 5Ca/5P particles were vapor deposited onto model 3-D 
porous fibrin scaffolds used for orthopedic tissue engineering [40, 50, 150] for 90 
seconds Figure 3.2). Control groups consisted of fibrin scaffolds not coated with sol 
particles and fibrin scaffolds coated with particles containing no calcium or phosphate for 
90 seconds. Fibrin scaffolds were generated by sintering 200µm diameter poly(methyl 
methacrylate) (PMMA; Polysciences Inc.) spheres at 145°C for 22 hours to generate 
molds. The molds were then immersed in a fibrinogen solution (200mg/ml in 0.9% NaCl; 
Sigma-Aldrich) and vacuum infiltrated overnight.  The fibrinogen infiltrated molds were 
then cross-linked in a thrombin (Biopharm Laboratories) solution and the PMMA beads 
were dissolved from the scaffolds by soaking them in acetone for 72 hours. Mineral 
crystal formation was induced on the vapor coated scaffolds by incubating them in 
simulated body fluid (SBF) at 37°C for 7 days. SBF solutions were changed every 3 days 
to replenish ions. Mineral crystal morphology and composition were analyzed with FE-
SEM imaging and EDS compositional analysis, respectively.   
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Figure 3.2. Application of vapor deposition methods. (A) Scaffold preparation: sphere-templated fibrin 
scaffolds were generated by vacuum infiltrating fibrinogen into a mold of sintered PMMA spheres, cross-
linking the fibrinogen with a thrombin solution and removing the PMMA spheres in acetone to create porous 
scaffolds. (B) Vapor-directed mineralization: porous fibrin scaffolds were placed in vaporization chamber and 
vapor coated with 5Ca/5P particles for 90 seconds. Vapor coated scaffolds were then immersed in SBF for 7 
days.  Methods for coating and inducing mineral growth on 2-D materials are similar to that seen in (B) 
Statistics 
 All experiments were performed in triplicate (n=3) unless otherwise stated. Data 
was analyzed for significance using an analysis of variance (ANOVA) and a Tukey’s 
post-hoc test for pairwise comparison.  Statistical significance defined as a p value less 
than 0.05 (p<0.05). Error bars in text and on graphs represent standard error of the mean 
(±SEM). 
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RESULTS 
Size Distribution and Morphology 
 The size distribution and morphology of particles loaded with calcium and 
phosphate and vapor deposited onto PS for 60 seconds was assessed. A deposition time 
point of 60 seconds was chosen because of the results seen in work up to this point 
showed similar effects to that of particles deposited for 90 seconds. The average area of 
25Ca/25P particles were significantly larger (0.24±0.02µm2) than both 5Ca/5P 
(0.12±0.02µm2) and 25Ca/5P (0.13±0.01µm2) particles (p<0.001) and were much more 
irregularly shaped (Figure 3.3A). The size distributions of the particles is similar for 
5Ca/5P and 25Ca/5P particles but 25Ca/25P particles had a much larger fraction of 
particles that were ≤0.0025µm2 (5Ca/5P = 0.17±0.01; 25Ca/25P = 0. 67±0.02; 25Ca/5P = 
0.18±0.01; Figure 3.3B).  
Figure 3.3. Morphology and size distribution of vapor deposited Ca/P sol particles. (A) SEM images 
show morphology of 5Ca/5P, 25Ca/25P, and 25Ca/5P particles vapor deposited for 60 seconds onto 
polystyrene. (scale bar = 10µm). Average area of particles was determined using an area-based MATLAB 
macro and 25Ca/25P particles were found to be significantly larger than both 5Ca/5P and 25Ca/5P particles. 
All comparisons were made using ANOVA, p-values < 0.05 were considered significant. Values expressed 
as ±SEM.  
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Surface Hydrophobicity 
 Deposition of 25Ca/25P and 25Ca/5P particles each significantly decreased the 
contact angle measurement (50.5±1.2° and 66.3±1.4° respectively) of the surface when 
compared to the PS plate controls (79.7±1.9°) and those coated with 5Ca/5P particles 
(74.4±1.1°), indicating that deposition of these particles makes the overall surface 
character more hydrophilic (p<0.04; Figure 3.4). Comparatively, the contact angle of 
TCPS, which has been plasma treated to allow for optimal cell attachment is 41.08±1.91° 
and PLLA, which is a highly hydrophobic, has a contact angle of 92.49±0.22°. 
Deposition of Ca/P sol particles lowers the contact angle to closer to that of TCPS.  
 
Figure 3.4. Surface hydrophobicity of vapor deposited Ca/P sol particles. (A) 25Ca/25 P particles have 
larger, more irregularly shaped particles that have a higher substrate surface coverage than 5Ca/5P and 
25Ca/5P particles. (B) Contact angle analysis shows that depositing Ca/P sol particles for 60 seconds 
decreases the contact angle of the substrate surface. 
Particle Degradation  
 The degradation behavior of the Ca/P sol particles in media at 37°C was found to 
be similar for all formulations except for at day 1 where Ca5/5P (56.1±4.3%) particles 
were significantly less degraded than 25Ca/25P (86.1±10.7%; p=0.03) and 25Ca/5P 
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(90.1±4.2%; p=0.048) particles, with all particles being over 90% degraded at day 7 
(Figure 3.5A).  Deposition of 25Ca/25P particles for 60 seconds led to significantly more 
total silica (0.014±0.003 mg/cm2) being deposited onto the substrate than for 5Ca/5P 
(0.025±0.003 mg/cm2; p=0.04) and 25Ca/5P (0.010±0.001 mg/cm2; p=0.01) particles 
(Figure 3.5B). 
Figure 3.5. Ca/P sol particle degradation behavior. The degradation behavior of 5Ca/5P, 25Ca/25P, and 
25Ca/5P particles is similar regardless of formulation, with over 90% of particles degrading in within 7 days.  
(B) Deposition of 25Ca/25P particles resulted in significantly more total silica (mg/cm2) being deposited onto 
substrates than 5Ca/5P or 25Ca/5P particles. All comparisons were made using ANOVA, p-values < 0.05 
were considered significant (* indicates statistical significance). Error bars and values expressed as ±SEM. 
Mineralization  
 Ca/P sol particles were vapor deposited onto PS plates for 60 seconds, with 
uncoated PS and PS coated with Ca/P free particles for 60 seconds to serve as controls, 
and after exposure to SBF for 7 days mineral growth was assessed. SEM images show 
that apatite-like mineral growth occurred in all groups, but mineral growth was much 
more advanced in samples coated with all Ca/P particle formulations, though their 
morphologies vary (Figure 3.6). EDS analysis showed that the Ca:P ratios for this 
mineral is similar for all Ca/P formulations (5Ca/5P = 1.29±0.08; 25Ca/25P = 1.32±0.02; 
25Ca/5P = 1.29±0.03; p=0.8).  
3-D Application of Vapor Deposition Methods 
 3-D porous scaffolds were either left uncoated (Figure 3.7A), coated with Ca/P 
free particles for 90 seconds (Figure 3.7B), or coated with 5Ca/5P particles for 90 
seconds (Figure 3.7C) and exposed to SBF for 7 days all showed apatite-like mineral 
71 
 
 
 
growth on the surface of the scaffolds. However, mineral growth was most significant on 
scaffolds coated with Ca/P particles, with the mineral crystals uniformly covering the 
scaffold surface. EDS analysis or the mineral on scaffolds coated with 5Ca/5P particles 
revealed a Ca:P ratio of 2.08±0.13.   
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Figure 3.6. Apatite-like mineral growth with Ca/P sol particles. SEM images of mineral growth induced by PS Controls, Ca/P free particles, 5Ca/5P, 
25Ca/25P, and 25Ca/5P particles deposited onto PS for 60 seconds after exposure to SBF for 7 days. All three Ca/P particles formulations show more apatite-
like mineral growth than either the PS controls or the Ca/P free particles.  
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Figure 3.7. Apatite-like mineral growth on 3-D porous fibrin scaffolds. Sphere-templated fibrin scaffolds vapor coated with (A) no particles, (B) particles 
containing no calcium or phosphate for 90 seconds, or (C) 5Ca/5P particles for 90 seconds and exposed to SBF for 7 days. Scaffolds with no particles show 
minimal mineral growth, while scaffolds coated with Ca/P free particles show more apatite-like mineral growth. However, scaffolds coated with 5Ca/5P particles 
show uniform apatite-like mineral growth on the entire scaffold surface (EDS analysis shows calcium to phosphate ratio (Ca:P) of 2.08±0.13).  
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DISCUSSION 
 Sol-gels can be used as carriers for an abundance of molecules including ions, 
proteins, drugs, RNA, and DNA. This work aimed to incorporate calcium and phosphate 
into the developed vapor deposited particles to make them more bioactive. The addition 
of these ions will change how the internal silica network forms, so it was necessary to 
characterize the morphology and size distribution of the particles. Particles resulting from 
5Ca/5P and 25Ca/5P solutions had regular rounded morphology similar to that of 
unloaded particles (Figure 3.3, Figure 3.8). However, 25Ca/25P particles were more 
irregularly shaped. This may be due to the water that is added to the solution with the 
addition of the ions, but is unlikely because the particles did not crack as the excess water 
evaporated, leading to the conclusion that this change in morphology is due to the 
increased concentrations in calcium and phosphate. Additionally, the average particle 
area was larger for all three Ca/P sol particle formulations, than for particles without the 
ions (0.076±0.01 µm2 at t=60 seconds). This could be due to the more disrupted silica 
network in the Ca/P sol particles through the addition of ions. Phosphate is known to 
increase the surface area when incorporated into a bioactive glass [144, 147-149]. The 
fact that the Ca/P sol particles generated have a relatively wide size range may be 
beneficial to bone formation. Bioglass particles with narrow (300-360µm) and wide (90-
710µm) size ranges were implanted into femur defects. At 4 and 12 weeks, the defects 
amount of bone generated in the grafts using the wide size range particles was larger and 
had biomechanical properties equivalent to native bone [151]. 
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Figure 3.8. Size distribution and morphology of vapor deposited particles containing no additional 
ions. Sol-gel solutions containing no calcium or phosphate ions have similar size distributions and 
morphology to that of 5Ca/5P and 25%Ca/5P particles.  
Deposition of all three Ca/P particles onto substrates decreased the contact angle 
of the overall surface, making them more hydrophilic, with the largest change resulting 
from the deposition of 25Ca/25P particles. This may be due to the larger surface area that 
is covered by the larger 25Ca/25P particles, allowing for more interaction between water 
and the particles as opposed to the other two formulations, which generated smaller 
particles (Figure 3.4A).  
The sol particles degraded more quickly with the addition of calcium and 
phosphate ions (day 1: blank = 36.3±4.6% degraded; 5Ca/5P = 56.1±4.3%; 25Ca/25P = 
86.1±10.7%; 25Ca/5P = 90.1±4.2%). This is due to the effect that calcium and phosphate 
ions have on a bioglass network. The connectivity of a bioglass network is determined by 
the composition and synthesis method of the glass. When the content of silica is high, the 
network is highly connected and contains a large proportion of bridging oxygen bonds. 
Connectivity is lowered by adding network modifiers (e.g. calcium and sodium) that are 
known to disrupt the silica network through non-bridging oxygen bonds [107, 152, 153]. 
Conversely, phosphate that is added to a bioglass is found to be isolated from the silica 
network and can remove calcium ions from their network modifying role, leading to 
faster release into the aqueous environment and making the bioglass more soluble overall 
[107, 154, 155]. 
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Though the particles successfully induced apatite-like mineral formation on 2-D 
substrates that was superior to the mineral growth on uncoated PS substrates and PS 
coated with Ca/P free particles, the Ca:P ratio was only around 1.3 for all Ca/P particle 
formulations. Native bone HA is often defined of having a Ca:P ratio of 1.67 so most 
bioactive materials aim to induce mineral formation at this benchmark. However, the 
actual Ca:P ratio for bone mineral ranges from 1.57-1.71, and changes with the stage of 
mineral maturation-increasing from 1.35 in early calcification of nodules [156] Altering 
the amount of calcium and phosphate available for release within the particles to the 
aqueous environment may lead to changes in the composition of the apatite mineral 
formed on the substrate to achieve a Ca:P ratio closer to mature bone HA. It would also 
be beneficial to determine the mineral composition in vivo since this would more 
accurately determine particle ability to generate mineral that is close to that of native 
bone. The calcium and phosphate Ca/P formulations that were used in this work were 
chosen because the addition of higher concentrations of calcium chloride and triethyl 
phosphate (i.e., 5M and 10M solutions) resulted in particles that were irregularly shaped 
and varied greatly from sample to sample (Figure 3.9). It has been noted that successful 
incorporation of calcium ions into silica nanoparticles makes it difficult to generate 
particles of a more regular morphology [107, 157]. A 25 v/v% solution (1M) was chosen 
because the addition of higher concentrations was found to have a dilution effect on the 
solution. This resulted in a limit on the amount of calcium and phosphate that could be 
incorporated into the sol particles using this technique and led to a fairly low amount of 
calcium and phosphate in the overall composition of the particles, especially when 
compared to that of traditional melt bioglasses which can be composed of up to 50 mol% 
calcium [158]. A possible solution to this is adding the calcium and phosphate solutions 
at the beginning of synthesis during hydrolysis, before the silica network has had a 
chance to form or through careful adjustment of sol pH [107, 159].   
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Figure 3.9. Examples of Ca/P sol particles generated from higher concentrations of calcium and 
phosphate. Solutions where higher concentration of CaCl2 and TEP were added [(A) 5 v/v% 10M Ca/5 v/v% 
5M P, (B) 25 v/v% 5M Ca/5 v/v% 5M P, (C) 25 v/v% 5M Ca/25 v/v% 5M P] resulted in particles that were 
highly irregular in morphology, composed of multiple phases, and displayed significant variability between 
batch preparations, for this reason 1M solutions were chosen for generating Ca/P sol particles. 
Vapor deposition of Ca/P sol particles and successful mineral growth on porous 3-
D scaffolds illustrates that these particles have the potential for application to structural 
biomaterials used in tissue engineering. The mineral growth on the 3-D scaffolds had a 
Ca:P ratio that was higher (2.08±0.13) than that of the mineral generated on 2-D 
substrates using the same Ca/P formulation (1.29.±0.08). This is because the generated 
mineral composition is dependent upon many factors including ion concentration, pH and 
movement of the body fluid, as well as the spatial organization of the surface [114, 160]. 
Additionally, the presence of a polymer (in this case: fibrin) can alter the composition of 
the mineral due to the incorporation of the polymer into the mineral layer [160, 161]. The 
high Ca:P ratio of the 3-D mineral indicates that it is highly insoluble, as mineral 
solubility increases with decreasing Ca:P ratios. This system developed here is a simple 
and versatile platform for Ca/P sol particle generation and upon further optimization, it 
could be possible to generate several different formulations of Ca/P sol particles-some of 
which could be used promote interface stability and others that could be applied to tissue 
engineering constructs. However, more work will need to be done in order to overcome 
some limitations including the thickness of scaffold that the sol particles can penetrate 
into. Potential solutions to this problem could be the application of a low-level vacuum to 
the vaporization chamber to pull sol particles through the scaffolds as they are being 
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generated and deposited or by incorporation of the sol particles into the fibrin structure 
itself to create a polymer-ceramic composite material.  
CONCLUSION 
This work establishes that vapor deposited particles with incorporated calcium 
and phosphate ions can successfully induce apatite-like mineral on both two- and three-
dimensional substrates superior to the mineral generated on untreated controls and 
samples coated with Ca/P free particles, demonstrating their potential to be used as a 
surface modification technique for other biomaterials to increase their bioactivity. 
However, further work needs to be done to improve the properties of the particles-
specifically increasing particle stability in order to prolong the physical (generated 
topography and increased surface hydrophilicity) and chemical (ion release) properties 
that result from the vapor deposition of these particles onto surfaces, as well as 
optimization of calcium and phosphate content used, in an effort to further tailor the 
composition of the resultant mineral.  
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CHAPTER FOUR: OSTEOBLAST RESPONSE TO 
CALICIUM-PHOPHATE SOL PARTICLES3 
This chapter addresses Specific Aim 3—assessment of osteoblast behavior in response to 
the vapor deposited calcium-phosphate loaded sol particles characterized in Chapter 3 
and evaluation of their of potential to be used to direct osteoblast attachment, 
proliferation, and differentiation in orthopedic tissue engineering applications. 
INTRODUCTION 
Native biological tissues are complex and composed of a variety biomolecules to 
create a heterogeneous environment whose structure is organized so that it creates a 
hierarchy ranging from nano- to micro- to macro-scale [162-165]. The physical and 
chemical properties of the tissue generate a particular set of cues for cells to promote 
proper cell behavior [164, 166-168]. Biomimetic materials aim to imitate the natural 
cellular micro-environment in order to promote tissue regeneration. More specifically, it 
is important to design materials with the minimal character to target desired cell behavior 
for tissue regeneration [168-175]. 
Surface roughness and topography, as examples, can significantly influence 
osteoblast behavior. It is widely accepted that implants with roughened surfaces display 
increased osseointegration [65-70]. Osteoblasts cultured on materials with high surface 
roughness (100-500nm) display increased attachment, compared to cells cultured on 
smoother substrates [176-183].  The coexistence of hierarchal nano- and micro-structures 
on a substrate surface (Figure 4.1) allows for greater interaction between the cell and the 
material and can induce both osteoblast proliferation and differentiation [183, 184]. Cells 
cultured on these materials have been found to have higher ALP activity, type I collagen 
and osteocalcin expression, prostaglandin E2 (PGE2) and transforming growth factor 
beta 1 (TGF-β1) production, as well as calcium deposition [80, 163, 183-186]. 
Additionally, the organization of the nano- and micro-structure can have a significant 
effect on osteoblast behavior. Less ordered surface topography results in increased 
3 The material presented in this chapter is in preparation for submission to the Journal of Biomedical 
Materials Research Part A. [Snyder KL and  Rajachar RM]. 
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osteoblast phenotypic character compared to that of highly ordered arrays in which cells 
develop a fibroblast phenotypic [80].  
In addition to surface roughness and topography, surface hydrophobicity 
(wettability) can also play a significant role in protein adsorption and cell behavior [57, 
187-189]. Hydrophilic surfaces (θ < 65°) allow for enhanced interaction between a 
substrate surface and its biologic environment, due to the ability to form covalent, ionic, 
hydrogen and charge-transfer bonds leading to increased cell adhesion and spreading [57, 
190-195]. Osteoblasts exhibit elevated osteoblast specific gene expression (osteocalcin 
and osteoprotegrerin) as well as increased prostaglandin E2, transforming growth factor 
β1, and vascular endothelial growth factor (VEGF) production, ultimately demonstrating 
increased differentiation on substrates that are more hydrophilic [182, 196-199]. 
Importantly, surface hydrophobicity effects on cell behavior are time dependent, guiding 
early activation and differentiation with effects that diminish over time (within 3 days) 
[57, 200].  
Silica based bioactive glasses, including sol-gels, possess the ability to actively 
influence cell behavior including osteogenesis and angiogenesis, as well as enhance 
antibacterial activity (see Figure 1.7) [4]. In addition to roughness, topography, and 
hydrophobicity, dissolution ions (Si, Ca, P) introduced to the surrounding medium have 
been found to influence the behavior many tissue specific cell types including 
mesenchymal stem cells, osteoblasts, osteoclasts, fibroblasts, and endothelial cells [4, 
104]. 
Osteoblasts exposed to silicate ions show increased proliferation, collagen I 
production (10-20µM), ALP activity, osteocalcin expression, and ECM mineralization 
(15-20µg/ml) depending on the concentration of silica ions and cell line used [117, 118, 
120, 122, 201]. Extracellular calcium and phosphate ions can have a significant impact on 
osteoblast proliferation, differentiation, and ECM production [12]. Calcium acts as a 
signaling molecule in many cell processes and pathways and can promote osteoblast 
migration, proliferation, and differentiation through the activation of calcium sensing 
receptors (CaSR/CaR), the extracellular signal-regulated kinase (ERK 1/2) pathway, and 
increases in intracellular calcium levels, with maximum effects being treatment dosages 
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between ~3-10mM [123-125, 202-204]. Phosphate ions (5-10mM) also play a role in 
bone remodeling and help to regulate osteoblast differentiation, increasing expression of 
transcriptional factors (e.g. Nrf2, HMGA1 and 2), signal transduction factors (e.g. 
calcyclin, A170), plasma membrane and membrane transport factors (e.g. Pit-1, Annexin 
V), as well as the extracellular matrix protein, osteopontin [128, 130].  
Again as with other material properties, the influence of dissolution ions is dose 
and time dependant in nature. Osteoblast precursors exposed to calcium ions at 
concentrations slightly higher than physiologic levels (2-4mM) show increased cell 
proliferation, while at even higher levels (6-8mM) differentiation and matrix 
mineralization are enhanced, but with a decrease in cell viability [126]. Excessive 
calcium levels (>10mM) are cytotoxic [5, 125, 126, 205]. Similarly, treatment of cells 
with phosphate ions causes a dose and time dependant (high concentrations and exposure 
times) increase in chondrocyte and osteoblast apoptosis, while also contributing to 
terminal differentiation [128, 132, 133]. For example, treatment of osteoblast-like cells 
with Pi for 48 hours at concentrations of 5 mM and 7mM led to 75% and 40% cell 
viability respectively, while after 96 hours of treatment with 5 mM Pi led to 30% viability 
and  7 mM caused almost complete cell loss [132]. Ion concentrations that are 
appropriate to ensure viability, while promoting cell differentiation and matrix maturation 
remain unclear, and understanding the mechanisms controlling these relationships 
warrants further investigation.  
The Ca/P sol-particles developed and characterized in Chapter 3 allow for the 
modification of biomaterials by generating unique surface nano- and micro-topography 
and decreasing surface hydrophobicity. These particles also release calcium and 
phosphate ions as they degrade and induce apatite-like mineral formation. The goal of 
this work is to assess osteoblast behavior in response to these vapor deposited Ca/P sol 
particles. Cell attachment, proliferation, and gene expression were evaluated. 
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Figure 4.1, Diagram of interaction of bone tissue and cells with a material at different topographical 
scales. From Gittens et al. with permission (see Appendix A) [184].  
MATERIALS AND METHODS 
Sol Preparation and Vapor Deposition 
 The base compositions of the sol solutions used in these experiments was a 16:1 
molar ratio of de-ionized water to tetramethyl orthosilicate (TMOS; Sigma Aldrich). Sol 
was vapor deposited using the developed vaporization chamber onto non-tissue culture 
polystyrene (PS) for 60 seconds at 40psi. Samples were removed immediately after 
deposition and the sol was allowed to fully polycondensate into a solid gel for 2 minutes. 
Samples were covered and stored at 25°C for 3-7 days until further use.     
Calcium and Phosphate Incorporation into Sol 
 Calcium (Ca) and phosphate (P) ions were incorporated into solutions just before 
vapor deposition by adding 1M calcium chloride (CaCl2; Sigma Aldrich) and 1M triethyl 
phosphate (TEP; Sigma Aldrich) in three different formulations  (v/v%): 5% Ca/5% P, 
25% Ca/25% P, and 25% Ca/5% P. 
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Cell Attachment and Proliferation 
 MC3T3-E1 Subclone 4 osteoblast progenitors (ATCC) were cultured directly on 
plates coated with particles (5Ca/5P, 25Ca/25P, 25Ca/5P, and Ca/P free) or non-tissue 
culture PS as a control (seeding density: 1x104 cells/cm2) at 37°C and 5% CO2 in 
Minimal Essential Media (α-MEM; Hyclone) supplemented with 10% fetal bovine serum 
(FBS; Hyclone) and 1% penicillin-streptomycin (P/S; Mediatech). All samples were 
sterilized using ethylene oxide and rinsed three times with sterile phosphate buffered 
saline (PBS) before cell seeding. At days 1 and 2, cells were fixed (4% 
paraformaldehyde), stained (TRITC-conjugated Phalloidin and 4',6-diamidino-2-
phenylindole, DAPI; Molecular Probes, Invitrogen), and imaged (Olympus BX5 
microscope). Cell attachment was quantified through direct cell counts and normalized to 
the cell seeding density.  
To determine cell proliferation, at days 1 and 2 cells were fixed (4% 
paraformaldehyde) and stained using the proliferation marker, Ki-67 (SP6) primary 
antibody (Abcam) with Alexafluor-488 conjugated secondary antibody (Abcam). Cell 
nuclei were stained using DAPI. Ki-67 positivity was quantified through direct cell 
counts and calculated by dividing the number of Ki-67 positive cells by the number of 
total cells [206].  
Gene Expression 
 MC3T3-E1 Subclone 4 preosteoblasts were cultured directly on plates vapor 
coated with Ca/P particles, Ca/P free particles or PS as a control (n=6/group) (1x104 
cells/cm2) at 37°C and 5% CO2 in α-MEM supplemented with 10% FBS and 1% P/S. At 
days 1, 2, and 4 RNA was isolated using TRIzol® (Invitrogen) according to the 
manufacturer instructions and RNA concentration and quality was determined using 
spectrophotometer readings at 230, 260 and 280nm (Nanodrop ND-1000). RNA was 
reverse transcribed into cDNA using Superscript® II Reverse Transcriptase (Invitrogen), 
1X first-strand buffer (Invitrogen), 48mM dithiothreitol (DTT; Invitrogen) 800µM 
dNTPs, (Promega), RNaseOUT™ Recombinant Ribonuclease Inhibitor (Invitrogen), and 
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0.5µg Oligo(dT)12-18 Primer (Invitrogen) at 42°C for 20 minutes, 50°C for 10 minutes and 
42°C for 60 minutes. cDNA was then used for real time PCR for genes of interest (GOI) 
and housekeeping genes (HK) (Table 4.1). All reactions were performed in the 
StepOnePlus™ real-time PCR system (Applied Biosystems) under the following 
parameters: hot start at 95°C for 15 minutes followed by 40 cycles at 95°C for 15 
seconds, 60°C for 30 seconds and 72°C for 15 seconds. GOI expression levels relative to 
the geometric mean of housekeeping genes Ubiquitin and Cyclophilin were calculated 
using the 2(-ΔΔCt) method [207]. 
Mineralization- Alizarin Red and Alkaline Phosphatase 
 MC3T3 preosteoblasts were cultured directly on plates vapor coated with Ca/P sol 
particles or PS as a control  (1x104 cells/cm2) at 37°C and 5% CO2 in α-MEM 
supplemented with 10% FBS, 1% P/S and 50µg/ml ascorbic acid. Media was changed 
every 3 days. At days 4, 7, 10, and 14 cells were fixed with neutral buffered formalin 
(NBF) overnight.  
 Cultures were stained for either calcium content (alizarin red) or alkaline 
phosphatase (ALP). For alizarin red, cells were stained (2w/v% alizarin red in dH2O and 
pH adjusted to 4.1-4.3) for 30 minutes at room temperature, washed with dH2O and 
imaged. For ALP activity, cells were stained with Naphthol AS-MX phosphate 
(0.1mg/ml)/diazonium salt (fast red violet LB salt; 0.6mg/ml) in 50% Tris-HCl (pH 
8.74)-50% dH2O for 60 minutes at 37°C, washed with dH2O and imaged. 
Statistics  
All experiments were performed in triplicate (n=3) unless otherwise stated. Data 
was analyzed for significance using an analysis of variance (ANOVA) and a Tukey’s 
post-hoc test for pairwise comparison, except for gene expression data where each 
treatment group was compared to controls using a Student’s t-test.  Statistical 
significance defined as a p value less than 0.05 (p<0.05). Error bars in text and on graphs 
represent standard error of the mean (±SEM). 
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RESULTS  
Cell Attachment and Proliferation 
 MC3T3 preosteoblasts cultured on substrates coated with Ca/P sol particles 
showed similar morphology to those cultured on polystyrene controls, with cells spread 
out on the substrate surface (Figure 4.2A). Relative cell attachment (normalized to 
uncoated PS) at day 1 (control = 1.00±0.15; Ca/P free = 1.59±0.22; 5Ca/5P = 0.97±0.07; 
25Ca/25P = 1.17±0.17; 25Ca/5P = 1.22±0.14) showed significantly higher attachment on 
plates coated with Ca/P free particles compared to plates coated with 5Ca/5P particles 
(p=0.0049) and by day 2 (control = 1.00±0.12; Ca/P free = 1.88±0.24; 5Ca/5P = 
0.79±0.11; 25Ca/25P = 0.91±0.07; 25Ca/5P = 0.84±0.08) significantly higher attachment 
on plates coated with Ca/P free particles compared to all groups (Figure 4.2B; 
p=0.0003). This indicates that cell attachment during days 1 and 2 is enhanced when Ca/P 
free particles are deposited onto PS substrate, while deposition of Ca/P particles does not 
increase cell attachment compared to controls.  
 Cell proliferation, as indicated by the fraction of total cells positively expressing 
of the proliferation marker, Ki-67 was assessed (Figure 4.3A). At day 1, the fraction of 
Table 4.1. Genes and primer sequences used in PCR reactions 
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Ki-67 positive cells (control = 0.53±0.03; Ca/P free = 0.74±0.04; 5Ca/5P = 0.45±0.02; 
25Ca/25P = 0.57±0.02; 25Ca/5P = 0.60±0.01), on PS coated with Ca/P free particles was 
significantly higher compared to PS controls and all Ca/P particle formulations 
(p=0.007). Additionally, the fraction of Ki-67 positive cells was significantly lower in 
5Ca/5P cultures compared to 25Ca/5P cultures (p=0.006). At day 2 the fraction of Ki-67 
positive cells (control = 0.78±0.04; Ca/P free = 0.74±0.03; 5Ca/5P = 0.58±0.02; 
25Ca/25P = 0.77±0.05; 25Ca/5P = 0.78±0.02) was significantly lower in 5Ca/5P particle 
cultures compared to all other groups (Figure 4.3B; p<0.006).  This indicates that cell 
proliferation is initially enhanced in cells cultured with Ca/P particles compared to 
controls while it is decreased in cells cultured with 5Ca/5P particles.  
Gene Expression 
 Gene expression of MC3T3 preosteoblasts cultured with Ca/P free and Ca/P sol 
particles was analyzed using quantitative PCR at days 1, 2, and 4. Osteoblast 
differentiation markers Runx2, osteopontin, (OPN), osteocalcin (OCN), and type I 
collagen were genes of interest and expression levels were normalized to housekeeping 
genes ubiquitin and cyclophilin (Table 4.2). There is a trend that is suggestive of an early 
up-regulation event of the master osteoblast differentiation regulator Runx2 expression in 
cells cultured with all Ca/P particle formulations at days 1 and 2 compared to controls 
(Figure 4.4A). Although the data did not reach the critical level for significance, these 
findings suggest that the presence of the particles themselves have the potential for 
accelerating commitment to an osteogenic phenotype. OPN expression was significantly 
increase in cells cultured with Ca/P free particles at day 2 (p=0.02) and shows a trend of 
upregulation at days 2 and 4 in cells cultured with Ca/P particles (Figure 4.4B). 
Similarly, OCN expression in osteoblasts cultured with Ca/P particles was upregulated at 
days 1, 2, 4 (statistical significance 25Ca/5P at day 2; p=0.001) and downregulated in 
cells cultured with Ca/P free particles at day 1 (p=0.02; Figure 4.4C). ColI expression 
was down regulated in cells cultured with particles (Ca/P free and Ca/P) at day 2 
compared to controls (statistical significance in 25Ca/25P cultures p=0.01; Figure 4.4D). 
The upregulation of Runx2, OPN, and OCN expression in osteoblasts cultured with Ca/P 
particles shows that they have to potential to induce early osteoblast differentiation.   
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Figure 4.2. Osteoblast attachment in response to Ca/P sol particles. MC3T3 preosteoblasts were cultured on non-tissue culture PS  dishes that have been 
vapor coated with Ca/P sol particles (5Ca/5P, 25Ca/25P, 25Ca/5P) for 60 seconds, with uncoated PS plates and PS plates coated with Ca/P free particles for 
60 seconds serving as controls.  (A) At days 1 and 2, cells were stained using TRITC-conjugated Phalloidin and DAPI and cell attachment was assessed (scale 
bar = 500µm). (B) Relative cell attachment (normalized to uncoated PS) at day 1 showed a significantly higher attachment on plates coated with Ca/P free 
particles compared to plates coated with 5Ca/5P particles and by day 2 significantly higher attachment on plates coated with Ca/P free particles compared to 
all groups. All comparisons were made using ANOVA, p-values < 0.05 were considered significant. Error bars represent ±SEM.(# indicates statistical 
significance to a second group within time point. * indicates statistical significance to all groups within time point).  
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Figure 4.3. Osteoblast Ki-67 expression in response to Ca/P sol particles. MC3T3 preosteoblasts were cultured on non-tissue culture PS vapor coated 
with Ca/P sol particles (5Ca/5P, 25Ca/25P, 25Ca/5P) for 60 seconds, with uncoated PS and PS coated with Ca/P free particles for 60 seconds as controls.  (A) 
At days 1 and 2, Ki-67 expression was assessed. (Inset- corresponding DAPI image showing cell nuclei; scale bar = 500µm). (B) At day 1 the fraction of Ki-67 
positive cells on PS coated with Ca/P free particles was significantly higher compared to PS controls and all Ca/P particle formulations. Additionally, the 
fraction of Ki-67 positive cells was significantly lower in 5Ca/5P cultures compared to 25Ca/5P cultures. At day 2 the fraction of Ki-67 positive cells was 
significantly lower in 5Ca/5P particle cultures compared to all other groups. All comparisons were made using ANOVA, p-values < 0.05 were considered 
significant. Error bars represent ±SEM. (# indicates statistical significance to a second group within time point. * indicates statistical significance to all groups 
within time point).  
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Table 4.2. Gene expression of MC3T3 osteoblasts cultured with Ca/P sol particles  
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Figure 4.4. Osteoblast gene expression in response to Ca/P sol particles. Quantitative PCR expression of osteoblastic differentiation markers (A) Runx2, 
(B) osteopontin (OPN), (C) osteocalcin (OCN) and (D) collagen type I (COLI) show relative gene expression levels of MC3T3 preosteoblasts cultured with Ca/P 
free, 5Ca/5P, 25Ca/25P, or 25Ca/5P particles deposited for 60 seconds normalized to cells cultured on untreated polystyrene (PS control) at days 1, 2, and 4. 
All comparisons between treatment groups and control were made t-test, p-values < 0.05 were considered significant (* indicates statistical significance 
compared to control) Error bars represent ±SEM.  
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Mineralization Alizarin Red and ALP Staining 
Cells cultured with Ca-P particles and stained for alizarin red after 14 days of 
culture show increased calcium deposition compared to controls especially in 5Ca/5P 
cultures, indicating a higher degree of mineralization in these cultures (Figure 4.5). ALP 
staining of cultures at day 14 was inconclusive (data not shown).  
Figure 4.5. Mineralization of osteoblasts in response to Ca/P sol particles. MC3T3 preosteoblasts were 
cultured on non-tissue culture PS  dishes that have been vapor coated with Ca/P sol particles (5Ca/5P, 
25Ca/25P, 25Ca/5P) for 60 seconds, with non-coated PS plates serving as controls (with and without media 
containing 50µg/ml ascorbic acid; AA). At day 14 cultures, were stained to assess calcium deposition 
(alizarin red) (scale bar = 500µm). 
DISCUSSION 
 Osteoblast attachment and proliferation in cultures treated with Ca/P sol particles 
showed no significant differences when compared to control cultures, with the exception 
of 5Ca/5P cultures at day 2, where those cells showed significantly less proliferation. 
When cells begin to differentiate, their proliferation rate slows [25]. This, in conjunction 
with the increased Runx2, OPN and OCN expression at day 1 and the increased calcium 
deposition (i.e. alizarin red staining) suggest that particles containing calcium and 
phosphate may enhance osteoblast differentiation.  
The gene expression data suggests that the there is a trend of upregulation in 
osteoblasts cultured with Ca/P sol particles when compared to control cultures. Runx2 is 
often considered the master transcription factor for commitment of cells to the osteoblast 
lineage in both endochondral and intramembranous ossification. Additionally, Runx2 is 
needed to ensure mature osteoblasts function properly by triggering their synthesis of 
many extracellular matrix genes, including type I collagen. Runx2 gene expression and 
protein function is regulated at various levels including transcription, translation, and 
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post-translational modification through a variety of pathways [208-210]. The data in this 
work is promising because without the upregulation of Runx2 expression, cells will not 
differentiate into osteoblasts. Additionally, the trend for up-regulated collagen expression 
in cells cultured with Ca/P sol particles further implies that these particles hold the 
potential to direct osteoblast differentiation with further modification of the system.  
When designing a silica based material for drug/molecule delivery there are many 
aspects that need to be taken into account including: the particle size, shape, and structure 
(pore network size, connectivity and volume). These properties can all be influenced by 
the synthesis parameters as well as any post-generation treatments such as thermal 
treatment or surface functionalization. Changing any of these features can dramatically 
influence the incorporated agents are released. Additionally, how the molecule interacts 
with the silica network will influence its ability to be incorporated as well as its release 
kinetics [211-214]. The influence of all of these factors is why developing a successful 
material system to deliver bioactive factors can be extremely difficult.  
The borderline significant differences in gene expression between control cultures 
and Ca/P sol particle cultures, indicates that the formulation of calcium and phosphate 
will need further optimization--possibly by increasing the deposition time of particles in 
order to increase the number of particles cells are exposed to and/or using a particle 
formulation with slower degradation characteristics in order to prolong the exposure 
particle material chemical (i.e. ion release) and physical (i.e. topography, surface 
hydrophobicity) properties to the osteoblast cells. Currently, the Ca/P sol particles 
designed in this work degrade within the first 3 days of culture, so any effects they induce 
are at the early time points. In order to fully induce osteoblast differentiation a threshold 
that was not reached with these particle formulations and/or sustained ion release may be 
required. 
Particle stability could be increased by aging particles using temperature curing 
for example. Increasing the drying time and temperature will promote the densification 
(decrease in pore size) of the silica network, thus controlling the degradation rate, which 
is especially important in systems designed for drug/molecule release [86, 105, 215, 216]. 
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Many sol-gel applications currently being developed involve a step where the material is 
heated to 400-600°C, which aids in incorporating calcium into the silica network as well 
as dramatically improving the stability of the material [217-220]. Though this step can 
help to improve the properties of the sol-gel material, it prevents the addition of any 
temperature sensitive polymers and/or biological molecules, thus limiting its use.  
 Perhaps a better solution to increasing the stability of the Ca/P sol particles is to 
generate an inorganic-organic hybrid material. These materials incorporate a polymer 
into the silica network at the beginning stages of sol-gel synthesis, so that the silica 
network forms around the polymer molecules (Figure 4.6). The two materials interact on 
the nano-level, allowing them to behave as a single phase material. Hybrid materials take 
advantage of the properties of both the inorganic (e.g. hardness, strength, thermal 
stability, density, etc.) and the organic (e.g. elasticity, hydrophobic character, chemical 
reactivity) components to generate materials that have improved mechanical and 
degradation properties that would not be possible otherwise [221]. For example collagen-
silica hybrid films (thickness = 100-200µm) degraded only about 50% of its mass in 14 
days in PBS at 37°C [222] In hybrid synthesis, the polymer is added to the sol-gel during 
condensation, where the chain-like structure of the silicate can entangle with the polymer 
chains [107-109]. Though hybrid materials have improved properties, there are several 
challenges that must be considered: 1) the chosen polymer must soluble in the sol–gel 
solution and have suitable degradation characteristics; and 2) the conditions in which sol-
gel is produced under can degrade the polymer so the pH must be carefully controlled to 
balance degradation and gelling time [107, 109, 110]. Currently polymers that are used in 
hybrid materials include poly(methyl methacrylate)-PMMA, poly(diemthylsiloxane)-
PDMS, poly(tetramethylene oxide)-PTMO, poly(2-hydroxyethyl methacrylate)-pHEMA 
,and  polycaprolactone-PCL, as well as the natural polymers gelatin, collagen, chitosan, 
alginate, and poly(γ-glutamic acid)-γPGA [7, 107, 221].  
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Figure 4.6. Schematic of an inorganic-organic hybrid material. The silica network is linked to the 
polymer chains by a coupling agent-the carboxylic acid groups on the polymer act as nuclophiles to form a 
bond. From Jones with permission (See Appendix A)[107]. 
CONCLUSION 
 The vapor deposition method established here allows for simple means of 
generating silica sol particles where calcium and phosphate ions can be incorporated. 
These Ca/P sol particles have been shown to hold the potential to direct osteoblast 
behavior. This system can now be optimized to address issues regarding particle stability. 
To address this, the development of an inorganic-organic hybrid material for the sol 
particles is an attractive approach.  
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CHAPTER FIVE: CONCLUSIONS 
SUMMARY AND KEY FINDINGS 
Six million bone fractures occur annually in the U.S., 5-10% of which result in 
non-unions or delayed unions indicating there is a growing need for the development of 
material substitutes and therapies to address this problem [1]. Tissue engineering and 
regenerative medicine have emerged in an effort to generate replacement tissues capable 
of restoring native tissue structure and function [2]. Because of the complexity of 
biologic systems, it has proved to be much harder to design substitute matrices for cells 
than originally anticipated. Cells are affected by the chemical and molecular composition 
of the implanted material, as well as by its physical properties. Development of materials 
that utilize the relationships between cells and material chemical, physical, and 
mechanical properties may provide a better platform for tissue regeneration [3]. Silica 
based bioactive glasses are most prominently associated with orthopedic applications in 
both traditional implants as well as hard and soft tissue engineering materials [102]. 
These materials have been known to enhance osteogenesis and angiogenesis as well as 
promote antibacterial activity [4, 223]. Sol-gels are attractive as a bioglass generation 
method because of their mild processing conditions, the ability to control structure and 
composition through their synthesis parameters, the ability to incorporate a variety of 
biological molecules, and their inherent biocompatibility [6, 7, 87, 88, 105]. Further, they 
possess the capacity to exert an inherent active influence on cell behavior; modulated in 
part by surface chemistry, topography, and active agents incorporated in the sol-based 
material.  However, the exact balance of these parameters that is most appropriate for 
directing cell function and gene expression is not fully understood and warrants further 
exploration [104, 205, 224]. The goal of this work was to develop and characterize a 
bioactive silica sol-gel surface modification system that can be used to tailor their 
material properties at the nano- and micro- level to better mimic the instructive 
conditions of native bone tissue, promoting appropriate osteoblast attachment, 
proliferation, and differentiation as a means for supporting bone tissue regeneration. The 
findings of this work are summarized below: 
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Chapter 2 
Vapor deposited silica sol-gel particle size distribution, morphology and degradation 
are dependent upon various formulation and manufacturing parameters including: 
H2O:TMOS, solution pH, underlying substrate character, and deposition time.  
• The H2O:TMOS affects particle size distribution through changes in the amount of H2O 
available for hydrolysis, which effects gelation time. At a ratio below approximately 8:1, 
increasing H2O content, decreases the gelation time, while at ratios above 8:1 the increased 
H2O acts as a diluent, causing a decreasing in gelation time [86, 105]. 
• Solution pH will significantly affect particle properties. Solutions near the silica isolectric 
point (pH=2-3) will have the longest gelation times and as pH increases gelation time 
decreases. Solutions with pH 5-6 have the greatest instability and quickest gelation time. 
Below the isolectric point the solubility of silica decreases and leads to metastable solutions, 
and a silica network has trouble forming [86, 105].  
• Substrate surface character plays a role in particle size distribution due to the interaction of 
substrate chemistry, hydrophobicity and roughness on the sol-gel as it is deposited.  
• Deposition time has a larger effect on particle properties when the sol formulation has a 
longer gelation time.  
• Deposition of sol particles changes the overall surface properties of a material, decreasing 
surface hydrophobicity and increasing surface roughness with increasing deposition time, as 
well as generating a unique surface topography.  
• Osteoblast attachment increases on substrates coated with silica sol particles during the first 
48 hours of culture due to both changes in the surface properties as well as silica ions release 
into the surrounding culture media.  
Chapter 3  
Calcium and phosphate ions can be incorporated into the vapor deposited sol-gel 
particles, and their size distribution and morphology is dependent upon the concentration 
of ions added, with higher concentrations of calcium and phosphate yielding larger, less 
rounded particles. 
• The degradation rate of Ca/P sol particles is largely independent of added ion concentration, 
with an average, effective mass loss of 90% within 7 days. 
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• Ca/P sol particles decrease overall substrate surface hydrophobicity, with increasing calcium 
and phosphate ion concentration.  
• Exposure to simulated body fluids generated apatite like mineral formation within 7 days for 
all particle formulations. 
• Ca/P sol particles can be vapor deposited onto three-dimensional porous scaffolds and induce 
uniform surface apatite-like mineral nucleation and growth, demonstrating potential use as a 
surface modification technique for bone tissue engineering. 
Chapter 4 
Osteoblasts cultured on Ca/P sol particles showed no significant differences in 
cell attachment within 48 hours compared to controls. Cell proliferation in these cultures 
was also similar to controls with the exception of cells cultured with 5Ca/5P particles, 
which showed decreased cell proliferation. This is promising, because differentiating 
osteoblasts have decreased proliferation rates [225].  
Gene expression in osteoblasts cultured with Ca/P sol particles shows a trend of 
up-regulated Runx2 expression. Runx2 is the master transcription factor in the 
commitment of cells to the osteoblast lineage [208, 210, 226]. Up-regulation of this gene 
shows the potential for Ca/P sol particles to aid in osteoblast differentiation.  
LIMITATIONS 
This work is limited by several factors including that many of the conclusions 
drawn regarding particle promotion of osteoblast differentiation are drawn from RT-
qPCR data. While this provides evidence of gene transcription, it does not necessarily 
show that the gene was translated into protein expression. Alizarin red and ALP staining 
attempted to demonstrate the calcium deposition (i.e., mineralization) and expression on 
ALP in longer-term cultures, but the ALP stain was inconclusive. A more reliable and 
quantitative method to assess protein expression would be western blotting. Additionally, 
gene expression was only assessed at early time points. This may not have captured the 
whole picture of how Ca/P sol particles influence cell behavior at later time points.  
Perhaps the biggest limitation of this work is the stability of the generated 
particles. Both unloaded silica and Ca/P sol particles degraded quickly when in culture 
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(within 7 days), with the majority of degradation occurring within the first 3 days. This 
limited the time that the particles were able to influence cell behavior, specifically full 
differentiation of preosteoblasts and bone matrix production. If the degradation rate of the 
particles could be slowed, their effects-induced both through changes in substrate 
physical properties as well as chemically through the release of calcium and phosphate 
ions could be sustained and have a greater impact.  
FUTURE DIRECTION 
Hybrid Materials 
 Incorporation of an organic material into the sol-gel formulation could greatly 
improve the degradation properties of the particles. Polymers added to the solution early 
in the sol-gel process allow the organic and inorganic portions to mix and interact very 
closely with one another so that they behave as a single phase material [107, 108, 220]. 
The polymer chosen must be soluble in the sol-gel solution and the solution pH must be 
carefully controlled to prevent polymer degradation as well as control the gelation time 
[107]. Additionally, a hybrid material may alter the release characteristics of the Ca/P sol 
particles, allowing for the incorporation of different concentrations of calcium and 
phosphate and sustaining their release during culture.  
Applications 
 The particles developed in this work could be used in a variety of applications. 
They can be used to coat a variety of biomaterials, from three-dimensional scaffolds (see 
Figures 3.1 and 3.6) to electrospun fiber mats (Figure 5.1), generating unique composite 
composition and architecture. Many other biomolecules could be incorporated into these 
sol particles in addition to calcium and phosphate ions in order to further enhance 
osteoblast differentiation including but not limited to bone morphogenic protein (BMP), 
transforming growth factor-beta (TGF-β), fibroblast growth factor (FGF), vascular 
endothelial growth factor (VEGF), insulin-like growth factor (IGF), and parathyroid 
hormone (PTH) [227-229]. A potential clinical application for these particles is with bone 
allografts. Allografts are limited in their osteogenic and remodeling potential, with 
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approximately 25-35% failing within 3 years due to fracture and nonunion. At 10 years, 
the failure rate has been reported to be as high as 60% [230]. Coating these materials with 
vapor deposited sol particles containing osteogenic factors may aid in integration of the 
graft with native bone tissue and potentially reduce local immunogenicity.  
In addition to orthopedic applications, the particles developed in this the work 
have the potential to be used in a variety of other applications. Bioactive glasses have 
recently been used in both soft tissue repair and angiogenesis [4, 223, 231]. Fibroblasts 
and endothelial cells treated with bioactive glass particles have been found have 
enhanced proliferation as well as produce high concentrations of VEGF, which stimulates 
angiogenesis [232-234]. Vapor deposition of sol particles onto biomaterials designed for 
soft tissue or cardiovascular applications may enhance effectiveness of these materials. 
Further, these particles may be used to enhance the antimicrobial character of 
biomaterials, by damaging bacterial cell structures, preventing biofilm formation through 
increases in local pH. Incorporation of known antibacterial agents such as silver (Ag+) 
ions and NO donor groups into the particles may further enhance these properties [4, 6].  
Figure 5.1. Vapor deposition onto electrospun fibers. Particles were vapor deposited onto electrospun 
PLLA fibers (arrow indicates vapor line created by masking) to demonstrate a potential application of 
particles on a relevant biomaterial surface.  
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